Background: Complementary therapy at UCLH is extensive and growing; with fourteen part-time therapists the service offers such diverse therapies as: refl exology, aromatherapy, Reiki and art therapy. The department recorded 6,101 separate therapy episodes last year. Funding for the department comes from a variety of sources, much of it from charitable funds. Without feedback from service users many of these groups lack the data to inform continued commitments to therapies; consequently, The Cancer Services Complementary Therapy Team (CTT) at University College Hospital (UCH) undertook a clinical service improvement project to evaluate the usage and reported satisfaction of the various complementary therapies used by patients in both the in-patient and outpatient setting(s). Methodology: The CTT developed a self-selecting, sample from the Cancer Services patient population who were receiving complementary therapies at UCH. Patients were asked to evaluate complementary therapies, the delivery of these therapies, and how useful they have found them in their care and treatment. The therapies were evaluated using a self-report questionnaire consisting of eight short sections, using a combination of closed, multiple choice, a free text opinion option, and a ten-point satisfaction scale. Results: 168 questionnaires were distributed, and 157 (93%) completed questionnaires were analysed. 75 (48%) respondents received therapy as an in-patient and 52 (32%) as an out patient. 91 (58%) had previously received complementary therapy at the hospital. Reiki was by far the most popular therapy (118, 75%) which is consistent with department data for the preceding 12 months, which noted 3,792 (62%) episodes of Reiki therapy were given across the hospital. Asked to rate the likelihood that more therapy would be requested in the future (using a ten point scale), 120 patients (76%) were extremely likely to request more therapy and a further 26 (17%) highly ranked this possibility. Qualitative analysis was overwhelmingly positive (111, 71%) and provided useful guidance for targeting resources: psychological effects and how they manifested in physical wellbeing were commonly mentioned. Discussion: The qualitative analysis, not fully reported in this abstract, provides signifi cant insight into the reasons people use complementary therapy and how they feel about what it can do to help them during treatment. The data emphasises the popularity of complementary therapies.
Introduction: The diagnosis of cancer is an unfavorable event for patients and their families. Therefore, patients need the management of their disease strong supportive car and high knowledge of their situation. So, the nurses can play a significant role in protection and education of the patients. Methods: The study has been done on 30 patients in BMT wards from August 2005 for one year. The diagnosis of patients were CML, AML, ALL and A.A. The ages of patients were between 16-53 years old. The conditioning regimen consists of Busulfan 4 mg/kg for 4 days and Cyclophosphamide 60 mg/kg/daily for 4 days. All patients have undergone allogeneic peripheral blood stem cell transplantation. 1) Assessment of economical, social and psychological.
Status. 2) Educational programs.
3) Responding to their questions and listening to their problems. 4) Using the supportive sources. 5) Evaluation of their reaction to their disease and therapies . 6) Encouraging them to express their feeling. 7) Using the educational fi lms and booklets. 8) Introduction the previous patients to them. Results: All the patients and their families cooperated with the nurses and accept their therapeutic plans. The anxiety and stress of patients were reduced, and their families felt comfortable. Conclusion: The nurses in BMT wards had a very important role in introducing the needs of patients to their families. They helped the family of the patients to understand about the disease and necessary therapies for that. So by suitable and on time education, the nurses could have a signifi cation role in reducing the somatic and psychological complication of HSCT and also promoting the outcomes of patients.
P1122 Nursing care in stem cell transplant A. Mousavi, Z. Adinegi Tehran Medical University of Scienses (Tehran, IR)
Introduction and aims: Nursing role to patients problems before and after transplantation due to psychological and organic aspects, Chemotherapy (CT) and its side effects (mucositis, infection after neutropenia), care of central venous access, timing and features of GVHD ( GI, Hepatic and Skin) and its follow up, transfusion, vital signs, intake-out put and electrolyte balance and nutrition is very important. In this insolated ward, nurse's role to evaluate economical, cultural and psychological state of patients and to coordinate them with physician is also important. Conditioning regimens administered before transplantation to make enough space for cells and to suppress the immunity of patients. Materials and methods: Between 2004-2006 on 300 patients with diagnosis of AML, ALL, CML, Myeloma, Lymphoma, aplastic Anemia and thalassemia major, allogeneic or autologous stem cell transplantation was done. This paper is descriptive study on these patients. Finding: According to nursing cares, problems with central venous catather (e.g. Infection), side effects of CT (hemorrahagic cystitis, cardiac and pulmonary problems), problems due to transfusion, neutropenic problems (infections, diarrhea and fever), GVHD and psychological problems, diminished in patients before and after discharge. Conclusion: To develop nursing cares has major role in diminishing side effects of stem cell transplantation. • review the goals of the chemotherapeutic.
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• review the schedule and rationale for diagnostic.
• provide the patient and family members with information on when and how to contact the nurse or the physician.
• reviow of the psychotice and emotional problem.
• reviow care of the venous access. Conclusion: Learning that some one in the family has cancer is an emotional thing for patient. They might feel fear, anger, loss of control, depression, despair, anxiety, help esslness, loneliness, guilty, confused. In fact they are likely to feel different things at different times. If you help your patient stay informed and connected they will have an easier time coping with the changes that cancer brings.
Stem cell source P1124
In-ward low-volume bone marrow harvest and direct intrabone injection for the treatment of poor graft function: the nurse's contribution M. Vicini, M. Brambilla, I. Battini, M. Bernardi, F. Ciceri, J. Peccatori, V. Matozzo IRCCS Ospedale San Raffaele (Milan, IT) Background: Intravenous injection is the standard method for transplanting hematopoietic cells. In a recent trial (Frassoni et al., 2008) , direct intrabone cordblood transplantation showed to overcome the problem of graft failure even when low numbers of HLA-mismatched cord-blood cells are transplanted, thus leading to the possibility of use of this technique in a large number of adult patients. We postulated that direct intrabone transplantation of a lowvolume of donor bone marrow (BM) cells could improve haematological recovery in the recipient as a result of better stem-cell homing, in patients suffering from allogeneic poor graft function. The procedures of both donor bone marrow harvest and intrabone injection have been performed in an operating room under general anesthesia. We hypotized to perform both procedure in an IN-WARD setting.
Here we describe the contribution of nurses in setting-up the entire protocol for both procedures. Methods: The relevance of nurse's contribution to the overall procedures is related to the following steps: a) preparation of all the items for the marrow harvest and transplantation, including the set-up of a protective environment; b) nursing support to the anaesthesiologist in the anaesthesia procedures based on a short propofol sedation; c) nursing support to haematologist during the bone marrow harvest and intrabone injection. Results: Two patients have been selected for primary or secondary graft failure. Once donor sedation was established, bone marrow harvest was realized through a standard procedure. Once obtained a total volume of 150-200 ml, donor BM is analyzed and sorted in multiple 50 ml syringes; fi nally a sedation of the patient is established and a needle for bone-marrow aspiration (14 gauge) is inserted once into the superior posterior iliac crest and the donor bone marrow is gently infused. The entire procedure lasted 1-hour including all the preparations and post-procedures set-up. A detailed picture documentation of the environment and procedures is available. Conclusions: An IN-WARD setting showed feasible in donor bone marrow harvest and intrabone injection for the treatment of graft failure. The contribution of nurses in setting-up the entire IN-WARD protocol for both procedures was relevant and represents a step forward in the general increase of the nurse's competences of a nursing team trained and dedicated to stem cell transplantation.
Stem cell donor

P1125 Guideline for tissue typing siblings for stem cell donation T.B. Soerensen Aarhus University Hospital (Aarhus, DK)
When stem cell transplantation can be the treatment for a patient, he always is asked for name and address of eventual siblings. Before we had a guideline, the siblings were asked directly to get through to the tissue typing laboratory to get tissue typed. The Department of Hematology did not have any contact with the possible donor before the patient and the donor was undergoing examination about 3 weeks before the transplantation. In that way it could happen, that a sibling donor was unusable, and we had wasted time, where we could have looked for a matched unrelated donor. Besides that, some patients and siblings could experience a kind of pressure for helping each other in this very diffi cult situation. Furthermore the siblings could have unanswered questions about donation stem cells which could make their decisions less qualifi ed. The objectives for making a guideline were to: • Optimize the work on fi nding a donor for the patient.
• Prevent delay of the transplantation because of the donor.
• Make the hospital responsible for the potential sibling donors in preparation for transplantation.
• Lighten the burden about fi nding a donor from the patient.
• Be sure, that siblings have suffi cient knowledge to accept being a donor, if the patient is undergo-ing a transplantation. The guideline prescribes among other things sending a letter with written information about stem cell col-lection, donation, voluntariness, and about diseases or other conditions which can make donation impossi-ble. The potential sibling donors are asked to call the hospital, if they are not completely healthy or get any kind of treatment. The siblings are also informed about our professional secrecy. This is very important, because we can uncover information, they do not want their family to know about.
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A standard letter and a written standard donor information is connected to the guideline. Making a guideline have resulted in:
• That all siblings now receive the relevant information.
• That all siblings know where to direct their questions and who to contact with health information.
• That all contact between the siblings and the hospital goes directly and not by the patient.
• We have got focus on ethic issues about tissue typing siblings in the department. The conclusion is that the guideline ensures a qualifi ed handling of siblings in the department, and that patients don't waste their precious time waiting for the right donor.
P1126
Active role of nurses in preventing and managing of adverse reactions in PBSC donor: a single-centre experience S. Zlebnik, A. Nunar, S. Prtenjak, D. Domanovic Blood Transfusion Centre of Slovenia (Ljubljana, SI) At the Blood Transfusion Centre Ljubljana of Republic of Slovenia we perform various apheresis procedures: thrombocytaphereses, granulocytaphereses, lymphocytaphereses, erythrocytaphereses and collections of peripheral blood stem cell (PBSC). It is crucial that performance of such high demanding specialized procedures is done by technicaly well trained nursing staff. Nurses have to do their best for meeting donors and patients needs and expectations on fi rst place. Provided that communication is fl awless, patient and donors feel much more comfortable. In addition tasks nurses have to deal with assembling the kit, venepuncturing, blood sampling, administrative work reffering to tests and results as well as monitoring the whole procedure from technical aspects. From January 2005 to November 2009, 346 patients and 65 eligible donors were submitted to 598 PBSC collection (518 for autologous and 80 for allogeneic transplantation). All collections has been performed using Amicus cell separators (Fenwal) by small-volume leukocytaphereses procedures. To prevent citrate -related side effects, calcium was oraly given to all patients (2 tablets in between procedure). Despite this preventive mesaures in 15 (2,5%) collections donors developed signs of hypocalcemia manifested as tingling around the mouth, hand, feet and shivering. This was managed with extra oral calcium supplements and/or by slowering the fl ow rates. In 3 (0,5%) procedures intravenous calcium gluconate was infused. In 14 (2,4%) procedures we stopped the collections early on because of nausea, vomitting and pain. We had to repeat venepunctions in 42 (7%) procedures due to poor venous access. For the same reasons, double-lumen femoral catheter was inserted to 60 (10%) patients. Regarding machine problems we had to stop the procedure in 6 (1%) collections. Diffi culties with kit occurred in 19 (3,1%) collections. Our experience, based on data, shows that well informed patients and donors manage to deal with procedure with less diffi culties. Talking and explaining to patients and donors is essential to make them feel less pain and tenseness. All these measures, taken before, between and after the procedure, help to create good relationship between patients or donors and medical staff.
P1127
Umbilical cord blood, precursory cells of life R.M. Torres Muñoz, J. Jimenez Martinez, R. Muñoz Montaño, I.M-. Durán Sánchez, S. Dávila Quintana, R. Ortega Carrión, V. De la Osa García, M. Aguilar Roman Hospital Virgen del Rocio (Seville, ES) Introduction: From 1997 it is had in Spain six autonomic public banks destined to take care of the transplants of the sanitary network coordinated by the National Organization of Transplants (ONT). Total of units obtained in 2008 got to be 34,000, some of them were destined to transplant outside of Spain and it is hope to arrive at 60.000 in four years. Andalusia is the fi rst community which authorizes to all his hospitals for the collection of umbilical cord blood. Objective: To present the foundations, advantages, disadvantages, mechanism of harvesting and processing of the donation of umbilical cord blood. Material and method: Bibliographical search on the donation of umbilical cord blood. Actual situation in Spain and Andalusia of the mechanisms of harvesting of the umbilical cord blood and their use for transplants. Results : Procedure of collection of umbilical cord blood, processing and conservation: 1. Informed consent. 2. Property of umbilical cord blood: donation allows 3 types of different donors:
• Auto-donation or for own use.
• Directed donation or familiar donation.
• Donors out of his or her family (altruistic). 3. Privacy and confi dentiality.
Procedure of collection:
Umbilical cord blood is toke after the birth, in the fi rst minute of life and after cutting the umbilical cord. Blood bags will be used. Puncture zone is cleaned with a no-iodine antiseptic and the umbilical vein in the distal end is canalized. It is drained by gravity while the placenta is still into the uterus. The collection of umbilical cord blood is not dangerous. 5. Storage of full bags: They will be possible to be maintained into a refrigerator to 4°C. 6. Transport to a conservation center for its analysis, processing and cold maintains. Conclusions: Nurses must be informed of the process of donation of umbilical cord blood to can orient people who want to donate Umbilical cord blood of an altruistic way.
Graft-versus-host disease
P1128
Modulated local treatment of GvHD skin lesions in patients after allogeneic stem cell transplantation contributes to rapid skin recover D. Basile, D. Previtali, F. Buzzi, O. Forma, V. Matozzo, F. Ciceri IRCCS Ospedale San Raffaele (Milan, IT) Background: Acute GvHD (Graft versus Host Disease) is an immunitary reaction exercised by the donor lymphocytes against the host's skin, liver and bowel. The treatment of advanced stage skin lesions requires systemic and local treatment. Advanced stage skin lesions are particularly challenging and pose specifi c tasks to nurse care. Methods: From January 2009 to November 2009 we conducted an observational study in our 18 bedded transplant unit for adult patients. Over a period of 1 year we performed 82 allogeneic bone marrow transplants and 20 of those patients showed skin lesions GvHD from stage I to IV (according to the clinical grading Glucksberg scale). The local treatment approach was modulated according to the stage of disease. We treated patients who developed GvHD stage I-II with an emollient protective emulsion based on purifi ed omental lipids and patients that reached stage III-IV with collagenase and paraffi n gauze dressing and anti shear wound dressing over 1 year. The treatment was started when the patient showed GvHD stage I. Results: Fifteen/twenty (75%) patients developed GVHD stage I-II; the treatment whit an emollient and protective emulsion based on purifi ed omental lipids full contributed to full skin recover after a median of 15 days.
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Five/twenty patients (25%) that developed GvHD stage III-IV were treated with collagenase, paraffi n gauze dressing and anti shear wound dressing and full recovered in a median of 40 days. A serial picture documentation is fully provided. Conclusion: Local skin treatment with an emollient and protective emulsion based on purifi ed omental lipids + collagenase and paraffi n gauze dressing contributed to a rapid recover of advanced stage GvHD skin lesions. This treatment protocol, in addition to systemic GvHD therapies can improve the outcome of patients suffering from GvHD I-IV skin lesions. Further studies are needed in order to confi rm those very promising results.
P1129
Extracorporeal photopheresis in treatment of refractory graft-versus-host disease: a single-centre experience S.Q. Chui, F. Kassim, N. Othman, Y.K. Guan, T.C. Ong, K.M. Chang Hospital Ampang (Ampang, MY) Background: Graft Versus Host Disease (GVHD) is an important cause of morbidity and mortality among allogenic haematopoietic stem cell transplant (HSCT) recipients. Standard treatment of GVHD has been based on immunosuppression with various drugs which have signifi cant toxic effects especially infections. Novel and innovative immunomodulatory therapies have emerged and extracorporeal photopheresis (ECP) is one of them. Objective: We evaluated patients with acute or chronic GVHD post allogenic HCST who have underwent ECP in our centre. Patient characteristics, transplant details, GVHD description, ECP treatment details and treatment outcome were documented and analysed. Methods: ECP was done using THERAKOS. Patients underwent apheresis and the fi nal volume of peripheral blood mononuclear cells (PBMNC) were collected into a ultraviolet A (UVA) recirculating bag. This bag was be injected with 8-methoxypsoralen (UVADEX) and followed by photoactivation with UVA light. The UVA exposed cells were subsequently reinfused back to the patients. The ECP sessions were done daily for 2 consecutive days. These were repeated weekly for the fi rst month and subsequently every 2 weeks for the next 2 months and monthly for the next 6 months. The ECP was terminated if response had been achieved or if the treating physician deemed treatment was not appropriate anymore. Results: Until 31st October 2009, we had done ECP on a total of 8 patients who had acute or chronic refractory GVHD post allogenic HSCT. Results were summarized in the tables below. 5 patients were still alive and responded to treatment but 4 of them still required immunosuppressive therapies. One patient had complete response and was off immunosuppressive therapy. 3 patients had died of GVHD despite ECP treatment. Conclusion: ECP is a new method of immunomodulatory therapy which shows some effect on GVHD. Our single centre experience of this form of treatment showed that it is a feasible addition to the current armamentarium of drugs available to treat GVHD. The exact mechanism of action of ECP remains unclear. Gorgun el at suggested that ECP induces apoptosis of immunoreactive T cells. Better understanding of the molecular basis of this therapy would allow better patient selection and hopefully better treatment outcome of GVHD.
Infectious complications
P1130
Detecting fever during neutropenia F.K. Ploos van Amstel, M. van Vliet, C.M.J. Potting, J.P. Donnelly, N.M.A. Blijlevens Radboud University Nijmegen (Nijmegen, NL) Introduction: Patients treated with high-dose chemotherapy for haematological malignancies are expected to be profoundly neutropenic for at least 10 days. Consequently, they are at high risk for developing sepsis. Fever is the main sign of infection during neutropenia and untreated infection can rapidly progress to sepsis and lead to death as a result. Promptly instituted empirical broad-spectrum antimicrobial therapy at the fi rst sign of fever has been shown crucial to patient survival. Therefore it is important that the nurse detects fever as soon as it occurs and immediately starts appropriate antibiotic treatment. Patients and method: A retrospective study was undertaken using patient data and a specially designed register. Throughout 2008, nurses of the Haematology Department were requested to register the vital signs as soon as they detected fever for the fi rst time and also note the time. Afterwards it was established whether patients were neutropenic at the onset of fever. Data analysis was performed using descriptive statistics and correlation analysis. Results: In total, 94 out of 156 registration forms were useful. In total, 66 patients (70%) had received a stem cell transplant. Fever was detected in 47 of 92 cases (51%) in the evening and in 27 cases (29%) at night. Of the patients who received an autologous stem cell transplant, 14 (59%) developed fever between day 7 and 9 after transplantation. A weak positive correlation (r = 0.265, p = 0.010) was found between body temperature and heart rate. Conclusion: Fever was mostly detected in the evening and at night. There was a distinctive pattern of fever following autologous stem cell transplant. The defi nition of the critical period and the policy for monitoring vital signs of these patients needs to be improved. Measuring body temperature is the most important means of detecting infection. Recommendations: Nightly monitoring of vital signs, especially body temperature should be adopted for all neutropenic patients. Longitudinal prospective studies for all patients undergoing treatment of haematological malignancies are needed to identify and monitor the critical period around the onset of infection.
Early side effects / Late effects and quality of life P1131 Monitoring and treatment guidelines for late effects of HSCT patients K.S. Davis, J. Brennan Royal Marsden Hospital (Surrey, UK) Haemopoetic Stem cell Transplantation (HSCT) and cellular therapy are rapidly developing, highly effective modalities of treatment for a broad range of haematological malignant diseases. HSCT was originally conceived as a means of administering high doses of myelo-suppressive chemotherapy and irradiation followed by allogeneic transplantation. Unfortunately HSCT is associated with considerable early morbidity and mortality long term and patients remain at increased risk of premature death even 15 years after treatment (Ades et al., 2002) . The intensive and arduous, high dose treatment can damage healthy tissue in the process of destroying the disease. Optimising outcomes through prevention or early detection of complications remains a high priority (Andrykowski 1997) . Advances in care during and post HSCT have ensured the reduction of toxicity associated with this procedure with the result that survival rates post HSCT have improved considerably during the past 30 years (Laughlin 2004) . There is a growing population of patients with different needs from those in the immediate post transplant period and as this group of long term survivors increases, the long term impact of treatment and their particular needs are bcoming more apparant. Research studies addrsssing the issue of long term follow up have been recommended by EBMT and the Seattle Group (Vose 1992 , Micallef 2001 . Surviviors need to be regularly assessed in a transplant centre where they can be monitored for late effects of the treatment and access the care of a dedicated transplant team (Curtis 2000) . The introduction of late effects of HSCT was the focus of a practice development project undertaken by the authors. Our primary aim was to work with new guidelines in order to provide uniformity in care for patients who had received HSCT. New guidelines in to support our practice were initially developed by The Centre for International Blood and Marrow Transplant Research and were adapted for our own practice. Following implementation of the service, fi ndings revealed that the experience had been a positive one for our groupof patients who felt that theywere offered more support in a structured way.
This poster presentation will show how our transplant unit using adapted guidelines managed the process of change to accomodate the needs of patients with late effects of transplant issues and how we introduced a system of guidelines to ensure that all patients were given uniformity in care and follow up.
P1132
Reactions after transfusion of PRBCs and platelet units in patients undergoing allogeneic haematopoietic stem cell transplantation H. Makkieh, K. Zahran, G. Awad, M. Hassan, M. Fawaz, M. Hamandi, T. Jisr, A. Ibrahim Makassed Hospital (Beirut, LB) Between January 1st 2008 and June 30th 2009, 15 patients (pts) underwent allogeneic hematopoietic stem cell transplantation (HSCT) in the BMT Unit at Makassed University Hospital, Beirut-Lebanon. Allogeneic HSCT was performed for acute myeloblastic leukemia (AML) in 7 pts, acute lymphoblastic leukemia (ALL) in 4 pts, myelodysplastic syndromes (MDS) in 2 pts, severe aplastic anemia (SAA) in one pt, and Fanconi anemia (FA) in one pt. Median age at allogeneic HSCT was 33 years (11-52). There were 3 females and 12 males. Conditioning regimens consisted in Busulfan (16 mg/Kg) and Cyclophosphamide (Cy) (120 mg/Kg) for the pts with AML and MDS, fractionated total body irradiation (12 Gy) and Cy (120 mg/Kg) for the pts with ALL, rabbit-anti-human T-lymphocyte (ATG-Fresenius) and Cy (200 mg/Kg) for the pt with SAA, and ATG (Fresenius) and Cy (40 mg/Kg) for the pt with FA. Prophylaxis of GVHD consisted in Ciclosporin and short course of methotrexate. The median duration of hospitalization for the early phase of allogeneic HSCT was 50 days (31-67). During this phase, the pts received 50 PRBCs units with a median number of 4 (0-12) and 103 SD platelets units with a median number of 6.5 (1-19). Reactions occurred after 4 episodes of transfusion. They appeared between 10 minutes and 2 hours after starting transfusion. After transfusion of PRBC'™s units, reactions consisted in high grade fever which occurred in one (2%) out of the 50 episodes of transfusion, and was transient. Investigations did not show documented infection. After transfusion of SD platelets units, reactions consisted in cutaneous rash (urticaria) which occurred in 3 (2.9%) out of the 103 episodes of transfusion. The 3 episodes of cutaneous rash were successfully treated with steroids.
Care of the care-giver P1133 Quality of life in children and their primary caregiver post haematopoietic stem cell transplantation in Taiwan
Objectives: The purpose of this study was to investigate the quality of life (QOL) and its related factors in transplantedchildren and their primary caregiver. Methods: This research was designed as a cross-sectional study with purposive sampling by structured questionnaire; e.g. Quality Of Life for Children with Cancer (QOLCC) for transplanted-children, and WHOQOL-BREF for primary caregiver. Between November 2008 and February 2009, 37 children/caregivers pairs (22 female, 15 male children) were recruited from one medical center in Taipei, Taiwan. The patient characteristics was listed: mean age of children: 13 (7-20), autologous versus allogeneic as 5:32, benign versus malignant diseases as 18: 19, mean duration post transplantation: 4.5 (0.-11) years.
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Results: 1. QOL in children post HSCT
(1) They got the best QOL in Physical Scale Domain, and the worst in Cognitive Problem Module Domain among the six domains of QOLCC scale and the highest incidence of children's symptoms are fatigue, followed by skin symptoms and gastrointestinal discomfort. (2) Children transplanted prior to six months ago was better than those transplanted within six months in terms of Physical Scale, Psychological Scale, Disease and Treatment-Related Symptoms/Problems domains on the scale sheet of QOLCC. (3) Children¡¦s overall QOL was worse for those suspended from school than those either returned to school or homeschooled themselves in the domains of Physical Scale and Social Scale. (4) The higher frequency of clinic visits was associated with the worse QOL in the domain of physical Scale. 2. QOL of primary caregiver.
(1) They got the best score in the domain of Physical Domain, and the worst score in the Psychological Domain. (2) The frequency of clinic visits lowered the QOL in the Psychological and Social Relation Domain. (3) For higher-educated primary caregiver with bachelor degree or above, they had better QOL. 3. The correlation between QOL of children and their primary caregiver. The children's and their primary caregivers' QOL disclosed a positive correlation signifi cantly in all Domains. Conclusion: The results of this study should help nurses to gain a better understanding of the QOL and symptom distress in children and pointed out that children and their primary caregivers were demanded for further information and nursing, and they should be followed indefi nitely.
Complementary therapies
P1134
Effects of health status and physiological index by exercise programme in patients undergoing allogeneic blood and marrow transplant K.S. Kim Catholic University of Korea (Seoul, KR) This study had be to conducted to investigate the effects of health status and physiological index by exercise program undergoing allogenic blood and marrow transplant in patients. This study was conducted between the month of May and December of 2008. The subjects were a total of 34 patients; including 17 in the exercise and 17 in the control groups. The exercise program was made into three steps: 1) warming up, 2) walking in treadmill 3) cool down, Starting from the next day of administration, the exercise group was carried out 10 minutes walking for 4 weeks, which were increased to 20 minutes walking for 2 weeks during 6 weeks in hospital. Using the SAS program, the data was analyzed with Chi-2-test, Fisher's exact test, unpaired t-test, with repeated measures of ANOVA and Bonferroni multiple comparison. The results were as the following: 1. The health status of the exercise group was 103.70, significantly higher than the 97.11 of the control group (P = .028).
In the role limitation of physical of the exercise group had not changed, yet the control group had declined (P = .018). In the role limitation of emotion, the exercise group had not changed, however the control group was signifi cantly lower (P = .017). 2. The exercise group with 91.76 was signifi cantly higher than the control group at 84.70 in Karnofsky performance status scale (P = .003).
3. Physiological index; systolic BP, diastolic BP, pulse rates, Hb and Hct had not changed in both. In the aspect of the immune subset, CD4+ had not changed much in the exercise group (9.89%), whereas the control group decreased to 7.97% (P = .001). Very signifi cant changes were identifi ed between the both groups (P = .038). 4. The variation of vital sign; systolic BP (P = .001) and diastolic BP (P = .001) were signifi cantly higher in comparison of the fi rst week, but did not differ from the increased 20 minutes walks the 5th weeks in the exercise group. Pulse rates had increased until the fourth week (P = .001), but no further changes were noticed after fi fth week compared to the initial data. Also, myocardial oxygen uptake made no distinct comparison to the initial data. As a result, exercise programs in allogeneic blood and marrow transplant provide to be an effective intervention to increasing health status and Karnofsky performance status score. It was also suggested that, one of safe intervention was to keep stable vital signs.
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Nutrition support in allogeneic stem cell transplantation: comparison of standard and modifi ed regimens: single-centre experience Y. Veber, E. Kokunova, M. Smirnova, K. Kirillova, O. Ivanova, M. Kucher, B. Afanasyev St. Petersburg Medical State University (St. Petersburg, RU) Introduction: Adequate nutrition support (NS) during hematopoietic stem cell transplantation (HSCT) improves therapy tolerability and reduces frequency and severity of various complications. Purpose: In this study we have estimated in HSCT recipients the infl uence of standard and modifi ed NS regimes on therapy tolerability, occurrence of post-transplant complications and their severity. Materials and methods: We analyzed data from 38 allogeneic SCT recipients, 17 of them underwent allogeneic related HSCT and 21 allogeneic unrelated HSCT. 15 of the patients had acute myeloid leukemia, 14 acute lymphoblastic leukemia, 5 Hodgkin lymphoma and 4 non-Hodgkin lymphoma. Sex distribution was even -19 (50%) men and 19 (50%) women. Median age was 26,7 (17-54) years. Control group (n = 16) included patients with symptoms of gastrointestinal toxicity and caloric intake lower, then 70 % for 3 or more consecutive days. These patients received standard NS regimen consisting of enteral and parenteral nutrition. The second group (n = 22) received modifi ed NS regimen consisting of enteral low-bacterial diet with parenteral nutrition with additional glutamine support (0,35-0,43 g/kg/day iv) starting on day + 1 after HSCT. In both groups we evaluated nutritional status using anthropometrical indicators (height, weight, body mass index, arm circumference, thickness of skin-fat folds over triceps, shoulder muscle circumference) and laboratory data (total protein, albumin, transferrin, macronutrients, copper, zinc). Results: In group of patients who received modifi ed NS decrease in frequency of mucositis (86% vs. 94%) and severity of III-IV grade mucositis (27% vs. 41%), decrease of grade III-IV aGVHD (15% vs. 21%), less signifi cant decrease of anthropometrical and laboratory values was observed. Between the two groups there was no difference in time of engraftment and number of blood components transfused. Conclusions: Patients receiving modifi ed NS tolerate the fulldose conditioning regimens and immunological complications in early post-transplant period better, then patients on standard NS regimens.
S351
P1136
Improved symptom management by use of refl exology R. Radiano, R. Or, M. Lafair, M. Toledano Hadassah Medical Organization (Jerusalem, IL) Introduction: Patients undergoing Hematopoetic Stem Cell Transplantation (HSCT) receive pretransplant conditioning, involving high doses of chemo-radiotherapy. Post transplant, the side effects of the treatment are further increased by neutropenia-associated infections, gastrointestinal mucositis and Graft vs Host Disease. In addition to physical treatment-related symptoms, most of the patients suffer emotional responses such as stress, anxiety and fear. As refl exology is known to be effective in alleviating a wide range of physical and emotional symptoms, and the most suitable for thrombocytopenic-neutropenic conditions, it is considered to be the complementary treatment of choice for our patients. Methods: In order to optimize symptom management during the prolonged transplant process a combined approach was implemented in our department, integrating complementary medicine and conventional treatment. Based on patient needs and general condition, as well as reports from the nursing and medical staff, a joint decision is made by the medical and the nursing team for integrating refl exology into the conventional treatment plan. Then patients receive individualized refl exology sessions twice weekly from licensed professionals.
Results: It has been demonstrated that refl exology treatment can improve the patient's quality of life and noticeably diminish chemotherapy side effects, such as nausea, vomiting, pain, anxiety and insomnia. Thereby, refl exology may effect the whole cycle of Activities of Daily Living and improving general wellbeing and mood of the patients as well as compliance. It was also noted by the nursing staff that patients following refl exology sessions were more relaxed, had less complaints and have reported high levels of satisfaction from the treatment. Conclusion: There is no doubt that effective management of treatment side effects and improved patient well-being presents a signifi cant challenge for the multidisciplinary team. Integrating elements of complementary medicine emphasizes our continuous efforts towards highest levels of comprehensive care.
Ethical issues
P1137
Ethical cafés strengthen the team spirit H. Ekfors, U. Bladh Lund University Hospital (Lund, SE) No matter what profession you belong to in hematology, frustration and moral stress over ethical dilemmas is experienced. In the hematological care it's hard to know what's best for patient and to its family. Every problem experienced by the personnel can't be solved by more resources; ethical dilemmas have more than one solution. At the hematology dept. in Lund many of the personnel felt they stood alone when a moral dilemma arose. The dilemma often had to be solved quickly without support or no opportunity for refl ection. Ethical dilemmas are common when the prognosis is poor or when a positive prognosis changes into a negative. Ethical dilemmas take a lot of energy and generate stress. Most dilemmas tend to be discussed at the coffee brake, why it was decided to organize ethical cafés in a warm welcoming atmosphere for the whole team around the hematological patient. An ethical discussion forum seemed as a positive opportunity for the psychosocial environment and to create better understanding. There is always a need to speak about diffi cult things, and there is a possibility in ethical meetings to share experiences. There is also a need for knowledge and experience in ethical reasoning. The purpose of the cafés is to discuss ethical issues in a calm environment, focusing on the method for ethical reasoning rather than discussing specifi c patients. Objective: Following the launch of the new guidelines it was important that the knowledge of staff who have direct contact with the patients was assessed -both practical food based knowledge and awareness of the new guidelines. Methods: Staff who work in the haematology setting were approached by qualifi ed dietitians and asked to complete the questionnaire assessing their knowledge and understanding of the neutropenic diet, the hospital menu's and the use of the advice. All questionnaires were anonymous and staff were given an answer sheet following completion. The questionnaires were then gathered and reviewed. Results: 65% of staff are aware of the neutropenic diet sheet launched in the trust but 60% of staff felt they did not feel confident to answer patient's questions should they query the advice in the diet sheet. Only 26% of staff were aware that the hospital menu's were coded accordingly to allow patients to chose safely when neutropenic from the menu. Conclusion: This audit showed that nursing staff on the unit were not fully aware of the neutropenic diet, when to use it and did not feel confi dent to advise patients accordingly. This recognised a training need in the haematology department and varies ways to do this were identifi ed. Ideas around using the internet to inform staff, having note cards which are given to new members of staff and training sessions to up date staff on any changes within the trust. In disease groups across all years reasons for removal differ considerably: in Acute Myloblastic leukaemia (45%), and Acute Lymphoblastic Leukaemia (47%) patients, suspected infection was the major cited reason for line removal, compared with signifi cantly lower numbers in both Multiple Myeloma (29%) and Hodgkin's Lymphoma (23%), in these cases end of treatment is cited as the major reason for removal (35%, 30%). Discussion: The data are partially explained by the differences and duration in treatment regimens; however, there is a downward trend in line infections that leads us to speculate on what might have changed in the management of central venous catheters over the last fi ve years across all disease groups. The development of new guidelines such as ANTT and clinical care bundles might help to explain some of these changes.
P1139
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Single-centre experience on PBSC mobilization using plerixafor E. Dannie, H. Auner, J. Davis, E. Kanfer, A. Rahemtulla, K. Rezvani, J. Apperley Hammersmith Hospital (London, UK) Autologus stem cell transplantation is now an integral part of treatment for patients with multiple myeloma (MM) and relapsed non-Hodgkin's lymphoma (NHL). Obtaining suffi cient cells remains a challenge in using this treatment strategy, as a number of patients will fail mobilisation with conventional methods. The recent introduction of the CXCR4 antagonist Plerixafor provides an alternative mobilisation option. We report on harvest results using Plerixafor on 10 patients who have failed mobilisation with conventional therapy. The aim was to harvest suffi cient cells for at least one autologus transplant (2 × 10 6 CD34+ cells/kg) without the added risk of general anaesthesia for a bone marrow harvest. The data were collected retrospectively form case notes, drug charts, care plans and apheresis logs. Between October 2008 -July 2009 10 patients (4 males, 6 females, 7 MM and 3 NHL) of median age 60 years (range 55-71)) were mobilised with G-CSF and Plerixafor. The G-CSF dose was 10 μg/kg for 4-5days and Plerixafor 24 μg/kg11 hours before the harvest. Two procedures were planned for all 10 patients. All procedures were performed using the auto PBSC programme on the COBE Spectra with duration and volume specifi c to each patient. A total of 15 procedures were performed on the 10 patients. 1 patient needed only 1 procedure to secure the target cell dose, 7 patients needed 2 procedures whilst 1 patient failed to achieve a peripheral CD34+ cell count adequate to permit pheresis. The median CD34+ cell count pre harvest was 31 (range 9.2-116 × 10 3 /L) and the median harvest count was 1.35 (range 5.6-0.09 × 10 6 /kg). The drug was well tolerated. No adverse effects were reported except in one patient who developed diarrhoea and was treated with Loperamide. None of the patients reported any injection site reactions and no adverse effects were reported following discharge. The nursing input in this method of mobilisation was pivotal. It incorporated an educational element for both nurses and patients and the apheresis team. In conclusion Plerixafor is a valid alternative new drug that is well tolerated in patients failing conventional mobilisation.
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Plerixafor for stem cell mobilization in autologous transplantation: implications for the practice of nursing S. Reis, A. Ferreira Hospitais da Universidade de Coimbra (Coimbra, PT) Background: Before autologous transplantation, it is needed the mobilisation of stem cells into bloodstream and their harvest. This process may be more diffi cult in patients (pts) with several chemotherapy/radiotherapy treatments. Recently we have the possibility to use a new drug, PLERIXAFOR, which enables stem cells mobilisation, in cases where they can't be mobilised with traditional growth factors. Purpose: The purpose was to evaluate if Plerixafor administration in the stem cells mobilisation has different implications for the practice of nursing. Methods: This is a comparative study between two groups of pts:to one of the groups it was given Plerixafor in association with G-CSF, to enhance the probability of successful stem cells mobilisation, because it wasn't possible only with the traditional growth factors according to protocol (group A); the other group mobilised successfully with G-CSF alone (group B). We evaluated the duration of hospitalization, neutropenia and the transfusion requirement of the two groups. Results: Our sample consists of 16 subjects (8 patients received Plerixafor), 10 male and 6 female. As for the pathology, we assessed subjects diagnosed with Lymphoma and Multiple Myeloma. After a comparative analysis between the 2 groups, we found the following results: days of hospitalization (Median group A (MA) = 24 days vs. Median group B (MB) = 23 days); days of neutropenia (MA = 10 days vs. MB = 8 days); support transfusion (MAplatelets = 15U, MAred blood = 3U vs. MBplatelets = 10U, MBred blood = 2U). Discussion/Conclusion: The pts belonging to group A showing an increased number of days of hospitalization and neutropenia. We also came to the conclusion that this group is subjected to a greater risk of bleeding and long periods of tiredness, since they need an increased transfusional support. As far as the practice of nursing is concerned, our experience allows us to say that pts with higher risk of bleeding, and longer periods of asthenia need more support to meet their basic human needs, closer surveillance, emotional support due to the confi nement in isolation and a continuous and emphatic focus placed on patient education to prevent possible complications. If Plerixafor wasn't given to these patients, they would have to make stem cells harvest directly from the bone marrow, with all the risks that can arise from these procedures, mainly related to anaesthesia and other side effects, such as fatigue, lumbago, nauseas and pain in the harvesting place.
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Monitoring of nursing of children with Hurler syndrome in bone marrow transplantation with co-infusion of mesenchymal cells J. Couto, M. Correia, T. Barreiros Instituto Português de Oncologia (Lisbon, PT) Introduction: Mucopolysaccharidosis is an inherited metabolic disease in which there is a defi ciency of the enzyme a-L-iduronidase, and the carrier can not produce the enzymes that break the chances of polysaccharides, which accumulate in the lysossome. Is a change chromosomal lotus 4 (4p16.3) and the accumulated glycosaminoglycons: Dermatan sulfate and Heparan sulfate. Life expectancy is approximately 25 years. The incidence of 1:100.000 live births, the parents are carries of the disease and asymptomatic. The diagnosis is made through the following test: urinary screening, x-ray of the skeletan, polysomnografhy cardiac evolution and ophthalmologic evolution. There are three variants of this syndrome, with varying degrees, including the Hurler (severe); Hurler Scheide (intermediate) and Scheid (mild) .The treatment consists in enzyme replacement therapy, bone marrow transplantation, gene terapy and in accordance with the clinical outcome has also been used to co-infusion of mesenchymal cells. Case study: This case study a child of 21 months, with Hurler Syndrome, proposed for allogeneic donor family and co-infusion of mesenchymal cells. Conditioning with: Bussulfex, Cyclophosphamide and Monoclonal antibody (ATG). Prophylaxis of gralftversus-host disease (GVHD) tacrolimus and metrotexato. On exam, pre-transplant, has mental age 15,5 months, macrocephaly, psychomotor development reasonable dysmorphism with prominent high forehead, nose broad and fl at base, wheezing, hepatomegaly, kyphosis and scoliosis hump, muscoskeletal deformities, bilateral corneal opacity, delayed myelination and diffuse failure to ortica slight. Result: Reduction of toxicity of chemotherapy, more effective control gralft-versus-host disease, dependence of enzyme stability, improving the musco-skeletal and symptomatic improvement from the disease. Conclusion: It is important to support the multidisciplinary team, including team nursing, both to monitor the carrier on the disease and their family. According to clinical studies, the earlier the diagnosis, with rapid onset of the treatments with adjuvant bone marrow transplantation has the greatest effect on the attenuated declive development. The mesenchymal cells play an important role in protecting the gralft from the host. Prevention and early diagnosis can reduce the complications of pre-existing disease. The treatment is to provide better quality of life to patients with mucopolysaccharidosis and stop some disease outbreaks.
P1143
A nurse-based positioning of percutaneously inserted central cathethers in haematologic patients: a single-centre experience R. Destefanis, A. Assanelli, P. Brambilla, C. Corti, F. Ciceri, V. Matozzo IRCCS Ospedale San Raffaele (Milan, IT) Objective: To evaluate the success rate of insertion of percutaneusly inserted central catheters (PICCs), their duration and the short-and long-term compications in an onco-hematological setting. Study design: We started a prospective collection and analysis of the data of the patients who underwent PICC placement from January 2008 to November 2009, with a total of 122 PICCs insertions. A well-trained team of nurses supervised by medical doctors has been in charge of insertion and management of PICCs. Data regarding type of catheter, site of catheter placement, reason for catheter removal, duration of use of the catheter and the rate of complications have been prospectively collected.
Results: The success rate of PICC insertion was 85%, with no acute or late complications. The mean duration of PICC placement has been 54 days (1 ± 222 days). PICCs have been removed or not correctly inserted in 15% of the patients, because of local bleedings for multiple vein punctures or arterial punctures (9% and 1% respectively) and because of mechanical occlusions (23%). The PICC infection has been assessed by positive blood cultures and its rate has been 2%. The PICC correlated vein thrombosis rate was diagnosed in 4 patients (8%). Conclusion: Our initial experience confi rms that PICCs are easily inserted and convenient with an important vascular saving in onco-hematologic patients, in whom peripheral drip or central venous catheter insertion is not possible. The percentage of prematurely removed catheters seems acceptable as compared to other central vein devices, after a mean period of 2 months. Our data seem to suggest the need of a prospective comparative trial of PICCs and conventional CVCs in hospitalized patients requiring central access in a fi eld of a growing trend in many hospital hematology and oncology services to switch from use of cuffed and tunnelled CVCs to PICCs.
P1144
Nursing observational study of patients submitted to intrabone transplant of umbilical cord stem cells in single haematological institution S. Pautassi, M. Bodrero, B. Castellino, P. Franchino, C. Mina, A.M. Miino, S. Perucca, M. Piumatti, A. Ghiglia, A. Cavallo, D. Rapezzi, D. Mattei, A. Gallamini S. Croce e Carle (Cuneo, IT) Introduction: Haematopoietic stem cells (HSC) source is a critical phase for therapeutic success in the treatment of haematological tumors. Umbilical cord blood (UCB) is adopted for simplicity of collection, absence of donor risks and a great tolerance to human leucocyte antigen difference (Sauter 2008). Relative immunological immaturity of UCB reduces graft-versus-host disease (GvHD). In spite of an elevated concentration of HSC and of greater proliferative capacity, cord HSC absolute number is lower than in the bone marrow (0.5-1% vs. 1-3%). New administration route, via intrabone (IB) infusion, reduces HSC aspecifi c loss during procedure in UCB transplant (UCBt). UCB are concentrated in 5-mL syringes, infused in superior-posterior iliac crest under general anaesthesia (Frassoni 2008) . Although preliminary, clinical data underline a median survival to UBCt comparable with one of allogenic peripheral blood transplant (aPBt) (Michlitsch 2008). Objectives: Aim of this study is to analyze different clinical aspects in IB UCBt patients in order to improve quality of nursing assistance. Material and methods: We enrolled 5 adult patients (median age 45), that underwent a IB UCBt in our ward, affected with acute myeloid leukaemia (n = 3), non-Hodgkin lymphoma (n = 1), chronic lymphatic leukaemia (n = 1). Data were collected into a database including anagraphic data and 3 chronological phases: pre-UBCt (-1); UBCt (0), post-UBCt (+1) till discharge. We recorded different events in -1/0/+1 phases: fever, nausea/vomit, mucositis, pain, anxiety, depression, infections; bleeding, sovrahepatic veins thrombosis (SVT), GvHD. Results: our results are shown in Figure 1 . Engrafment median time was 21 days (n = 4). 3 deaths occurred within 38, 116, 232 days of transplant, all by pulmonary infection. Median discharge (n = 3) was 31.6 days from UBCt, 71 days in case complicated by SVT. Conclusions: Despite the small number (n = 5) of cases, we conclude that in +1 phase were present the same events found in -1 phase, in some cases onset. IB, although invasive, didn't cause infl ammation in injection site. Engraftment time, as reported in bibliography, results longer in comparison with aPBt. We conclude that careful observation of clinical aspects allows more accurate monitoring and prevention of adverse effects in order to improve nursing assistance of IB UBCt patients.
P1145 Is it magic? S. Vieira, K. Hii, D. Monroe The Trustee of London Clinic (London, UK)
Prelixafor is an antagonist of alpha-chemokine receptor CXCR and one of the new additions to Haematology. CXCR4 alphachemokine receptors are important in hematopoietic stem cell homing to the bone marrow and in hematopoietic stem cell quiescence. It is indicated to use in combination with Granulocyte Colony Sitimulating Factor (GCSF) for Peripheral Blood Stem Cell (PBSC) collections in Multiple Myeloma (MM) and Lymphoma patient group with a poor mobilisation history. At our centre, four patients received Plerixafor for PBSC. All patient met the criteria prior to treatment (White Blood Count > 2.5 × 10 9 /L, Absolute Neutrophil Count > 1.5X × 10 9 /L, Platelet > 85 × 10 9 /L, Serum Creatinine: ≤ 1.5 mg/dl, Aspartate transaminase (AST), alanine transaminase (ALT), Bilirubin: < 2 XULN, No evidence of Hepatitis B&C). All patient demographic data is shown in Table 1 . Only one patient had an underlying medical problem cortochondritis. Three of the patients included in this study were MM and one Hodgkin Disease (HD). All patients received four consecutive days of GCSF 10 μg/kg prior to Prelixafor. Prelixafor was given 10 hours before the PBSC collection and GCSF was repeated in the morning of the collection time. All patients received 0.24 mg/kg/day Prelixafor. There were no side effects observed. None of the patients required a second dose of Plerixafor, even though one of the patients had not reach the required 4 × 10 6 /kg. Conclusion: Plerixafor was used in our clinic recently with a good outcome. The target in each case was a total of 4 × 10 6 /kg CD 34+. One of the patients responded extremely well with a count of CD34 21.79 × 10 6 /kg achieved and one patient had poor outcome where only CD34+ count of 2.03 × 10 6 /kg were collected. The other two patients met the target with counts of CD34+: 7.39 and 4.62 respectively. According to this study Prelixafor has improved the PBSC outcome with one exceptional case. However it is inconclusive due to small patient numbers.
Outpatient developments
P1146
Nutritional support for patents receiving stem cell transplants: are patients receiving optimal nutritional support?
R. Clout The Christie Hospial NHS Trust (Manchester, UK)
Background: Patients receiving stem cell transplant are prone to varying degrees of gastrointestinal failure. Many patients experience signifi cant reduction in appetite & therefore reduced calorie intake within a few days of hospitalisation, associated with significant weight loss (Murray S 2008) . It is clear that clinical outcomes in malnourished groups are poor, compared to those receiving adequate nutrition (NICE 2006) . NICE recommend nutritional support should be considered in people who are malnourished and those with unintentional weight loss 10% within 3-6 months. JACIE standards stipulate there should be adequate dietetic cover for SCT patients. In addition, the DOH recommends that dietetic support should be available after discharge if required. Historically patients receiving allogeneic SCT on our Haematology & Transplant Unit would be referred to the dietitian on admission; however there is no follow up service available subsequent to discharge. Objectives: The primary objective is to review the percentage of weight loss up to a year post transplant. To examine support offered to allogeneic stem cell transplant patients and to review whether there is adequate dietetic support during the inpatient period and, perhaps more importantly on discharge. 75% of RIC patients had weight loss at 6 months post transplant ranging from 1-35% and at one year 65% still had a weight loss ranging from 5-27%. 85% of full intensity transplant patients had weight loss at 6 months ranging from -26% and at one year 66% still had weigh loss ranging from 5-27%. Most of the inpatients during their SCT were reviewed by the dietitian, but currently there is no dietetic follow up post transplant. Conclusion: The data confi rms that there is signifi cant weight loss in our transplant practice. Clinical guidance indicates that maintenance of nutritional status translates into improved outcomes. We are investigating how our data compares to other units who are fully compliant with nutritional guidance.
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Dry eye, symptom in graft-versus-host disease after stem cell transplantation A. Bondong, P. Dreger, E. Jakob, F. Mackensen University of Heidelberg (Heidelberg, DE) Haematopoietic stem cell transplantation is an established treatment for many patients with haematological diseases. Graft versus host disease (GvHD) is a typical complication, which can affect multiple organs. An important and frequent manifestation is involvement of the lacrimal glands resulting in the "Dry eye syndrome". It appears if the eye is moistened insuffi ciently due to reduced tear production. As a consequence, infl ammation of the conjunctiva and the cornea can occur, which can be very painful for the patient and may even lead in loss of vision. Since symptoms and pathogenesis of GvHD-associated keratitis are very similar to ocular autoimmune diseases, we have started a cooperative project with the Department of autoimmune Eye Diseases at the University of Heidelberg. A whole day has been reserved for transplanted patients per week, beyond this time patients can be already sent to begin with tear-fl ow screening-test. In addition, the patients fi ll in a questionnaire addressing dry eye symptoms. Treatment options comprise a spectrum of variable measures, which are used in a escalating manner according to the patient's needs: with low discomfort it can be sometimes suffi cient that the patient pursues regular eyelid hygiene; in a second step artifi cial tear drops are administered. More severe cases may require treatment with cyclosporine eye drops. As especially helpful are eye drops produced from patient's own serum. Physical possibilities include plugs reversibly obturating the tear duct preventing rapid loss of tear liquid and scleral lenses for more extensive couses. Surgical options include irreversible tear duct occlusion or transplantation of salivary glands from mouth to eye. Dry eyes affect the quality of life of a person considerably. Therefore we send our allogenic patients to the Dry Eye consultation hour as soon as even modest signs of chronic GvHD become apparent, even if the eye is clinically (still) not affected. Annually we transplant about 90 patients. In 2009 we saw about 70 patients with ocular GvHD -transplanted about several weeks until 9 years ago. So per month the Department of Autoimmune Eye Diseases at the University of Heidelberg treats about 25 patients with GvHD. From the Transplant patient case management's point of view, the "Dry Eye" cooperation project has resulted in signifi cant improvement of the quality of care and of the patient's well being and will be further intensifi ed in the future.
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Late effects following allogeneic stem cell transplantation in childhood are frequent and may markedly evolve quality of life A. Pertlova, V. Cepelakova, H. Sejkova, B. Nagyova, R. Formankova, P. Sedlacek, P. Keslova University Hospital Motol (Prague, CZ) The study of late effects following stem cell transplantation (SCT) is more important due to an increasing number of longterm surviving patients. There is a heterogeneous group of complications often not life-threatening but signifi cantly impairing the quality of life. At our institution we continue to follow our patients and we do not refer them to adult teams. We analyzed long-term outcomes in 152 patients (surviving 4-20 years) after allogeneic transplantation at our institution for malignant or non-malignant disease (acute or chronic leukemia, lymphoma, myelodysplastic syndrome n = 95, severe aplastic anemia, severe immunodefi ciency or metabolic disease n = 57). The age of patients at time of SCT was 0.2-20.5 years. So far we could document the incidence of late infections in 32%, pulmonary dysfunction in 36.6%, hypo-or hyperthyroidism in 32%, hypogonadism in 49%, growth impairment in 28%, cataract in 17%, bone and joint complications in 11.7%, cardiac complications in 6.5%. Secondary malignancy had occurred in 3.9% of them. Only 15-20% of patients did not suffer from any late posttransplant complication. The incidence and number of complications in long term survivors following allogeneic SCT in childhood are increasing in time. Treatment, nursing and social care of these patients and families is very exacting. Close cooperation of specialists, nurses, physical therapists and social workers is essential. Therefore we recommend a long-life multidisciplinary monitoring as an important part of post-transplant care. Supported by MZ0FNM2005 and EU grant 503223-LLP-1.
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Compliance with regular phlebotomy can reduce the long-term risk of iron overload following successful haematopoietic stem cell transplantation
A.G.M. Neuman-van Eijk, F.J. Smiers, L.M. Ball Leiden University Medical Center (Leiden, NL)
Chronic multiple red-cell transfusions are associated with long term organ toxicities related to iron overload. Hematopoietic stem cell transplantation (HSCT) is curative for a diseases associated with transfusion dependency. Persistent increased ferritin levels post transplant require treatment, otherwise it will cause irreversible organ damage. Other late effects of an iron overload are for example growth delay and vascular deviations of the retina. Children and parents consider continuing subcutaneous chelating treatments after successful HCST to be burdensome and side effects associated with oral chelating therapies may preclude such alternatives. Some children received oral Deferasirox (Exjade) that in some cases was discontinued because of toxicity, measured in the controls of liver and kidneyfunctions. Also the nausea was mentioned as a side effect. Other children received Desferrioxamine (Desferral) s.c., from experience with no serious side effects. An other oral medication is Desferiprone, but it is not used very much because of the risk of agranulocytosis. All this methods ask for a daily compliance and is experienced as burdensome by child and parents. We introduced regular phlebotomy post transplant in children with persistent high serum ferritin levels in order to increase compliance: Children with persistent ferritin levels > 1000 Ug/l at least six months post HSCT without evident infection or GvHD were considered suitable. Additional criteria included stable chimerism, transfusion independence with a Hb > 6 mmol/l. Patients were counseled by the transplant nurse practitioner, who arranged phlebotomy as an out-patient every 3-4 weeks. Ferritin levels were monitored to determine response. Children were assessed subsequently in the long-term follow up clinic associated with the HSCT unit. Ferritin levels post HSCT ranged from 1560-6650 ug/l. Our experience so far concerns 15 patients. At those, regular phlebotomy proved a more acceptable form of post transplant chelation treatment but required extensive counseling and support to ensure compliance.
P1151 Post-transplant follow-up on adult SCT-patients in Finland -enabled by patient's commitment S. Haavisto Helsinki University Central Hospital (Helsinki, FI)
The Division of Haematology of Helsinki University Central Hospital (HUCH) has the main national responsibility of adult stem cell transplantations in Finland with the exception of Turku UCH which takes care of SCT's for patients from the western part of the country. The main responsibility of the fi rst post-SCT year care lies in HUCH. The follow-up cannot primarily be performed elsewhere because of the special expertise on adult SCT's in HUCH. If a new SCT-patient is of some urgent reason admitted to another hospital than HUCH, close co-operation between health care professionals is required. The follow-up is very intensive. Patients visit the SCT outpatient unit at least once a week for the fi rst three months. If any problems do not occur, the visits can gradually take place less frequently with a two to four-week interval. Some of the visits include regular scheduled actions that together can last out nearly half a day. After one year post-SCT the follow-up visits occur approximately once a year up to 5 years post-SCT and after that every 5 years. Between the visits the patients are sent a questionnaire with a return envelope by post. The questionnaire is aimed to sort out possible late effects of SCT. The late follow-up visits are much awaited and the response rate for the questionnaires is nearly 100%. The follow-up system causes the patients supplemental strain, because most of the patients come from northern and eastern parts of the country. The longest distance between patient's residence and HUCH is nearly 1300 km. A patient can travel for 8 to 10 hours to get to Helsinki by 10 am. The follow-up actions at the outpatient unit take a few hours. The patient is then able to start the return-journey in the afternoon and maybe gets home some time before midnight. Repeating this once a week can be extremely exhausting during the fi rst post-SCT weeks and months. Despite geographical inconvenience and early convalescence the patients are very committed to their care right from the beginning and hardly ever miss an agreed-on visit. The patients constantly express their trust and very seldom want to discontinue the care. Supporting factors for the long-distance patients to cope the intensive follow-up are good connections and fi nancial support. There is a well-functioning public transport system in Finland which enables travelling all over the country. Also the Finnish Social Insurance Institution contributes commendable to patient's travel expenses.
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The treatment of patients with myelodysplastic syndromes in an era of application of new treatment modalities in an outpatient setting requires a multidisciplinary approach C.M. Eeltink, G.J. Ossenkoppele, A.A. van de Loosdrecht VU Medical Centre (Amsterdam, NL) Background: Myelodysplastic syndromes (MDS) are a group of heterogeneous clonal stem cell disorders that mainly affect the elderly population. The application of novel agents such as lenalidomide and 5-azacytidine may improve quality of life (QoL) and survival. However, these agents are not without side effects in the elderly population already at high risk to develop toxicity. Therefore, a multidisciplinary approach in an outpatient setting is highly instrumental in the treatment of patients with MDS. Methods: Aging is highly individualized, for that reason we assess at diagnosis the care needs of the elderly in order to organize coordinated and integrated health care. Apart from haematologists our team consists of a nurse practitioner. Guided by the problems we have encountered, the patient consults either the haematologists and/or the nurse practitioner at every visit. Goals: The goals of the multidisciplinary outpatient clinic are to prevent deterioration caused by these new drugs via a proactive approach. The treatment with newer agents or the supportive care in elderly patient with MDS is directed to improve the physical and emotional condition, the QoL and to ultimate prolong overall survival. An important task elicited by the application of new modalities is to anticipate on potential life threatening side effects (e.g. pancytopenia and renal impairment) and to motivate our patients to insist because drugs such as lenalidomide and 5-azacitidine require multiple cycles to exert their effects. Conclusion: Managing side effects in a group of elderly patients with MDS who have functional limitations, and who are dependent on others or susceptible to multiple illnesses and burdens is very challenging. Fatigue and loss of energy before and during treatment are among the most important sequelae for the patient. Treatment related pancytopenia and renal impairment during treatment can occur and need dose modifi cations. It is shown by this approach that treatment with lenalidomide and 5-azacitidine is feasible in this vulnerable population. This group of patients can benefi t from a multidisciplinary approach in an outpatient setting in which the nurse practitioner functions as a case manager.
Palliative care P1153 At the end-of-life care M. Rey González, M. Ruiz Seixa, R. Mérida Herencia, M.D. Alamo Pulgares HUVR Sevilla (Espartinas-Sevilla, ES)
Introduction: The palliative care according to the European society of Palliative Care "are comprehensive and total active care provided to patients with a disease undergoing advanced and progressive, potentially fatal short-term and no longer responding to the curative treatment. "In our society there is a negadora trend of death". The own or of someone you love is something to not be but that always the case. When someone sick and transcends the word "cancer or leukemia" to the environment, an alarm is triggered by the tragic consequences that these diseases bring with them. As the desired expectation is not always cure, patients and their families need support total, active and continuing an interdisciplinary team. Objective: Palliative care are at a time can be considered the greatest rise of public opinion, the professional nursing while in the history of the profession not overlooked needs faced by the patient in terminal phase, is currently the opportunity to work within a multidisciplinary team. For WHO the palliative treatment is aimed at: -Reaffi rm the importance of life, whereas the death as a normal process. -Establish a process to not expedite the arrival of death or postpone it. -Provide relief of pain and other symptoms. -Provide a support system to help patients to live a life as active as possible. -Provide support to the family so that it can tackle the patient's disease and cope with the period of mourning. Materials and methods Bibliográphic search. NANDA, NIC, NOC. Care plan to palliative patient. Results: Log diagnostic nurses (NANDA), results (NOC) and interventions (NIC). Coping defensive (00071) related to the disease itself, denial deterioration of body image. Despair (00124) related to decline or deterioration of the physiological state, long-term stress.
S357
Acute pain (00132) Chronic (00130) /pain related to ineffi cient management of drug therapy. Conclusions: Death with dignity and without pain is a right of the individual with terminal cancer and palliative care emphasize this precept, on the basis that this is an inevitable end, that the person concerned has to face, but requires the minimum suffering. Introduction: In the Clinical Unit of Hematology of Adults in the University Hospital "Virgen del Rocío" (HUVR) in Seville, Spain, the haematology patients under palliative care frequently, express their desires to go away to house when they inquire to them into which they do not have more alternatives of treatment. Nevertheless, they remain in the hospital, sometimes maintained with treatments that prolong their suffering to him, and mainly, their desires vanish to return to house before dying or to die in her. Objective: To know if the allocation of a nurse who knows his process and manages the sanitary resources, would increase the number of patients that decide to die in house, would diminish the sanitary cost and these would win in quality of life. We have carried out this research project within this context. Material and method: Design: Cuasiexperimental, longitudinal and prospectivo study. Hypothesis: The allocation of a referring nurse of the Unit of Clinical Hematology of Adults like manager of cases of palliative patients, increases the quality of life of the patients in safe surroundings as it is his home and it diminishes the sanitary expenses. One prolonged stay in the hospital generates expenses sanitary that can be saved and, in this way, to optimize the resources. Results: Until the moment we have made the pursuit of 13 palliative patients to whom we have mentioned in the hospital with unique appointment after making the analytical one to him, sometimes in the address, to manage with the reference hematologist necessary the Haemotherapic support, the patient only goes to the hospital when she has been received from the blood donation point packed cells or platelet, during his stay in the unit by day is visited by the doctor who modifi es the treatment if he needs. The obtained results can be applied to patients in situation of bad prognosis of their disease, or of the pathology that is, becoming tensile to the palliative cares of other specialties. Conclusions: 1. Haematology patients under palliative care requires of cares and a qualifi cation of the caretakers to face the necessities of the patient at the end of the life including his psicoemocionales necessities. 2. Haematology patients under palliative care and his family need the support professionals specialized in the pathology and equipped with professional competitions (knowledge, abilities and attitudes) that helps to confront the death with dignity. Background: Few data exist in literature concerning survey on application of recommendations for patients after allogeneic hematopoietic transplantation (HSCT) and these recommendations may vary between centers. Aims: The aim of this study was to establish a French survey of recommendations given to patients at discharge after HSCT through the "Société Française de Greffe de Moelle et de Thérapie Cellulaire" in order to propose a national homogenization for these recommendations. Method: Questionnaires were sent to 37 French centers asking them for details concerning their instructions to patients on discharge after HSCT. Twenty centers responded. When adults and children were transplanted in the same unit, 2 questionnaires (one for children and one for adults) were asked to the centers.
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Patient information and education
Results: Twenty-two questionnaires were received and analyzed: 15 for adults and 7 for children. Recommendations were orally given in 5 centers whereas a specifi c written documentation was given in the other centers. All patients had dietary recommendations (not detailed in this study). Recommendations concerning body care varied: hypoallergenic cosmetics in 45%, no deodorant in 30%, and soft brush tooth in 86% of centers. Housework and bedroom airing were considered to be done only when patient was out in 73 and 59% of centers. Condom use was recommended in cases of sexual relation by 70% of centers. Wearing mask was recommended systematically, under some conditions (neutropenia, high dose steroids) or never, respectively in 59%, 23% and 18% of centers. All centers advised their patients against public places and contact with infected people. At home, some other limitations were given: no contact with animals (91%), no gardening (86%), no newspaper touch (20%), no aerosol use (25%), and no solvent use (30%). Thirty-one percent of centers advised patients not to drive or ride. Smoking and alcohol drinking were included in recommendations for each of 80 and 95% of centers, respectively. Exposure to sunlight was forbidden in all centers. All these recommendations were raised according to different conditions: time from transplantation and immune recovery (immunosuppressive drugs, neutropenia or lymphopenia) in 82% or only immune recovery independently form the period post transplant in 18% of centers. Conclusion: Some recommendations varied a lot between centers, based on centers experience and literature; there is a need to give uniform guidelines, for patients after HSCT.
P1157
Working with children and adolescents after stem cell transplantation: an outpatient handbook L. Kovacejvic, C. Peters, A. Lawitschka St. Anna Children's Hospital (Vienna, AT) A large part of a child's care after receiving allogeneic hematopoietic stem cell transplantation (HSCT) takes place in an outpatient setting. Discharge from the SCT-unit is an extremely exciting, often anxious time for patients and families. To improve their ability to cope with their new lives and routine with hereby reducing fears is one of the main goals.
To provide patients and parents with comprehensive information and to improve their education in an entertaining way we developed an age-appropriate handbook.
This poster will demonstrate how we designed and produced this booklet and the benefi ts this provides to patients, their families and the SCT-staff. We created three versions: one version for school kids between 4 and 11 years of age, one version for adolescents between 12 and 17 years and one version for adolescents over 17 years and for parents. Age-adjusted language and layout was designed with the support of our psychological team and a graphic artist. Medical information had to cover medication, haematological reconstitution, organ toxicities, infections and prevention, and rehabilitation. A health dictionary was designed to help to understand diffi cult medical vocabulary and a chapter of nutrition and dietetics was added. Our guide intended also to give practical information about the SCT-Outpatient-Clinic and the services we provide. Last but not least interactive pages for questions and feedback were attached. Kids and parents did enthusiastically participate in the developmental process of our handbook and our multidisciplinary team was also involved actively. The booklet has removed the need for numerous sheets of paper and provided centralised information. It was produced at low cost at our department. Patients, parents and staff feedback was extremely positive and this Outpatient Handbook became another useful tool of communication in our department. (Figure 1 ). All received hospital specifi c information booklet & 95% (n = 19) considered it helpful. All found pre BMT clinic useful & 90% (n = 18) felt they were given enough information about different treatment options available. Majority felt length of time with BMT nurse & doctor was about right, however, 2 (10%) thought appointment was too short. All patients felt they received 'about the right' amount of information (Figure 2 Unlike many other European countries, direct involvement of the nurses in clinical research protocols has been always very limited in France. At time of creation of the TCN position in Nantes, a "clinical research mission" has been assigned. The aim of this report is to describe the role of the TCN in a protocol aiming to identify predictive factors for GVHD. The protocol was designed to perform a full set of investigations around day 30 after allo-SCT with the aim to identify biological, morphological and radiological markers that can be predictive of early onset of severe GVHD. In addition to drawing blood and plasma samples for immunological analyses, the protocol included the performance of a gut pet-scan, digestive endoscopies in those high risk patients for severe GVHD. After informed consent and inclusion of the patient by the transplant physician, the TCN had to meet with each patient in order to deliver further information, and organize a personalized "road map" of investigations that would limit the hurdles for the patients. Of note, the TCN had: -to draw blood and plasma samples as scheduled per protocol.
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-to organize the appointment and transport of the patient to another site of the university hospital where the gut pet-scan was performed; -to organize the appointment and transfer of the patient to gastro-enterology department where the video-capsule examination, digestive endoscopy and biopsies were performed. -to create a nursing schedule and database which allow for real-time follow-up of the different investigations. Between Jan. and Oct. 2009, 50 patients were included in this protocol. According to the physician decision, 16 patients had a video-capsule among whom 11 underwent digestive endoscopy. 44 out of 50 had the gut pet-scan. Analysis of the initial results is currently ongoing. Overall, the protocol could be run without any signifi cant incident. Patients' satisfaction was high. The TCN was able to play a key coordinating role with the different physicians involved in this complex protocol. Based on this fi rst experience, and given the crucial role of clinical research protocols in the management of allo-SCT patients, we conclude that the TCN can increasingly play a pivotal role in the organization and running of research protocols and therefore, an adequate training of nurses in the fi eld of clinical research is warranted.
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The fi ght has to be led together S. Flaujac, A. Guerraz, C. Jeannesson, O. Samsonova, A. Sarzier Edouard Herriot Hospital (Lyon, FR) An adequate management before, during, and after hospitalization is important for its good progress and for the patient's well-being. Numerous participants appeared these last years thanks to: -A national consciousness with the French «Cancer Plan» initiated in march 2003 under the Republic's President impulse, -A larger mediatisation of the hematologic pathologies with the emergence of numerous associations, information and prevention campaigns on donations of blood products, bone marrow, cord blood cells…; -The implementation, for some years, of " Patient's Days " during whom the physicians give their knowledge, answer the patient's or their families' questions, and allow them to testify about their stories and their evolution; -A medical and paramedical awareness in the acceptance of alternative methods of supportive care.
Thus new players have arisen within our institution, such as the teams of "palliative care" and "nurses in charge of patients' pain", hypnosis therapist, beauticians, a team of "relaxation exercises" and many regional and national organizations. Therefore, standardization of information for better supportive cares and better management becomes necessary. So, after having observed the patients, listened to their requests, those from the paramedical and medical staffs and distributed a questionnaire to these new actors of care, the creation of a booklet containing an evolving collection of information appears necessary. This booklet consists of writing clear and relevant information, which could be given early and integrated within the "welcome booklet". Consequently, the patient feels not alone and sees that he can rely on other people than the medical and paramedical staffs only. It is supported in its entirety and his personality, according to his status. Furthermore, this support is a help for the patient, giving him the opportunity to review the information after acceptance of the diagnosis and its therapeutic consequences. The clinical course seems therefore clearer and then played down to a more acceptable hospitalization duration. To conclude, our work ends by the development and dissemination of an explicative booklet which allows to get back on the information as the patient requires and the requests, as well as to facilitate better relationships between the patient, its family, the medical and paramedical staffs and new players in supportive care.
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My bone marrow transplant -patient booklet J. Cargill (1) The booklet has been designed by experts in the fi eld of paediatric haematology/BMT, child psychology/play and patients who have undergone a bone marrow transplant. Using actual footage of our BMT unit, illustration and text, the booklet describes the journey that the child will undergo in the process of preparing for transplantation and the procedue itself. The booklet will compliment existing prepartion material utilised within the Hospital and it is envisaged that we will audit its effectiveness through informal interviews with children and their carers.
P1163 Sssstop and learn S. Thompson, H. Cosh University Hospital of Wales (Cardiff, UK)
The Bone and Marrow Transplant Unit at the University Hospital of Wales in Cardiff is a level 4 centre serving patients from all over Wales who require transplantation. It has been an ongoing problem that information regarding transplantation given either verbally or written at consultation level is not retained. A novel idea for a poster showing the pathway through transplant using an age old fashioned, childhood game of "Snakes and Ladders" highlighting the 'up and down' was developed. Using this in conjunction with the Leukaemia Research Seven Steps booklet, we are hoping for a more positive understanding of the process. The poster is aimed not just at the patients but also their families, partners and carers as it was felt that they also struggle with retaining information regarding their important role prior, during and post transplant. Reducing anxiety levels and encouraging co-operation is conducive to a smoother journey and it is with this in mind the poster was established. 1. Indicate an improvement in the practice of staff. 2. Ensure that restrictions imposed on the patients are reduced more appropriately. 3. Make the transition to discharge is easier for the carers. This presentation will describe the process of changing our protective isolation guidelines, the diffi culties in changing long established practice and the outcome for the patients' staff and carers since changing this practice.
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The relationship between nurse aid and haematological patient undergoing transplantation T. Ummarino, V. Molinari, C. Carissimo, M. Galizio, F. Trenta, F. Conti, M. Brunetti, S. Soave, C. Cirri, A. Frusone, A. Gulli, G. Colandrea, M. Mauroni Policlinico Tor Vergata (Rome, IT) Background: The patient who undergo hematopoietic stem cell transplantation experiences a change in life style as he encounters problems related to social, emotional, professional, sexual and spiritual life. The present abstract is to suggest an observational survey regarding the comfort needs of the patient during the day hospital follow-up and the importance of the nurse in the therapeutic education, counseling and aid. Aim of the study: The aim of the study is to seek the major needs of the transplanted patients and of their relatives during the follow-up in day hospital, regarding the human approach with the nurse and the psychological and social aspects in the management of distress and fear. Materials and methods: The survey was carried out at the Policlinico of Rome "Tor Vergata", in the hematological day hospital. The sample examined consisted of 30 patients, males and females, between 40-70 years old, with a direct interview dialogue, by means of a questionnaire structured with close and open questions and responses. Results: This study was to investigate on patient satisfaction by asking whether they had obtained an appropriate assistance and 87% of the sample responded positively declaring to have received an effi cient nurse support based on trust. When asked which daily requirements the patient really needed, 37% replied to have been assured, 17% wanted to go back home, 13% expressed joy of life and the residual asserted serenity desires. The main natural characteristics of the nurse perceived by patients and their relatives during the relationship were for 53% humanity, for 15% patience, while the remaining sample requested professionalism, a smile and motivation. Discussion and results: This study suggested that the role of the nurse in day hospital is fundamental in establishing a trust relationship by means of a therapeutic communication which aims to improve self-esteem and self-care of the patient and the training of family care-giver. Conclusions: The nurse in day hospital owns advanced competences which beyond a technical qualifi ed assistance/aid, guarantees a therapeutic alliance/coalition that helps the patient to acquaint and handle in a competent way its proper style of life, preventing risk factors and complications, enhance own autonomy, in order to constantly improve the quality of life.
Psycho-social issues
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Interruption of the familiar processes during the process of marrow transplant V. De la Osa García, R. Muñoz Montaño, I.M. Durán Sánchez, S. Dávila Quintana, R. Ortega Carrión, R.M. Torres Muñoz, J. Jimenez Martinez, M. Aguilar Roman Hospital Virgen del Rocio (Seville, ES)
Introduction: In the Clinical Unit of Hematology of Adults (UCHA) at the Virgen del Rocío Hospital (HUVR), in Sevilla autólogos and alogénicos transplants of bony marrow are made. During the hospital stay, that is approximately of a month, the patient remains isolated, accompanied of his main caretaker and with restricted visits. This supposes a radical change of the normal life that not only it also affects to the patient and his caretaker but to the rest of the familiar unit what entails that in the plan of cares, inside of the pattern roll/relations is fundamental the activation of the interruption of the familiar processes. Material and methods: 1. Collection of data of clinical histories of patients transplanted in our unit.
Nursing diagnoses approved by the North American Nursing
Diagnoses Association (NANDA) up to the thirteenth conference.
Classifi cation of nursing outcomes according to Nursing Outcomes Classifi cation (NOC). 4. Classifi cation of nursing interventions according to Nursing
Interventions Classifi cations (NIC). Results: Within the pattern roll/relations the infi rmary diagnosis that appear most frequently is the Interruption of the familiar processes related to (r/c) change in the state of health of a member of the family. Conclusions:
• During the hospitalization the transplanted patient of bony marrow presents/displays an Interruption of the familiar processes due to the isolation necessary to prevent infections due to neutropenia. • The interruption of the familiar processes is one of the diagnoses of infi rmary of greater incidence in our unit.
• The main caretaker who throughout remains next to the patient the period of hospitalization, habitually is a basic member of the familiar unit what causes still more that the familiar life is interrupted.
• The nurse is the professional who detect these necessities and support emotional to the patient, main caretaker and rest of the family. Malnutrition leading to clinically apparent weight loss (WL) during allo-SCT results in weakness, delayed engraftment, immunosuppression and increased rates of GvHD. Significant WL is associated with increased mortality and results in signifi cantly longer in-patient stays with important cost implications. Our patients planned for a myeloablative (MA) allo-SCT are advised to have a nasogastric tube (NGT) inserted on day + 1 post graft infusion, prior to development of predicted mucositis. NG feeding is commenced if daily intake is < 1/3 of estimated requirements for > 5 days,< 2/3 of estimated requirement for 10 or more days or a WL of > 10% of baseline. Total parenteral nutrition (TPN) is indicated for patients unable to tolerate NG insertion/feeding. Prophylactic NGT insertion is not used in reduced intensity allo-SCT (RIC Rationale: The requirements for food and liquids and interventions to increase energy intake among patients undergoing allogeneic stem cell transplantation (SCT) are largely unknown. A three-phase food guideline has been developed at the Department of Hematology, Oslo University Hospital and contains a description of food and liquids, and interventions to increase oral intake. However, the guideline was mainly empirically derived and it is unknown if it fi ts the requirements of the patients on a daily basis. The aim of this study was therefore to examine if the food guideline was in accordance with the actual food and liquid choices of these patients. Methods: We collected data based on in-depth interviews from eight patients at the following time points: Days 2 or 3 pre-transplant, and days 9 or 10, and 20 or 21 post-transplant. The interviews consisted of open-ended questions about experience of: i) symptoms and ability to eat, ii) food and liquid requirements, and iii) intervention to increase oral intake. Results: In general, the quality of food and liquids (e.g. smell, taste, temperature, texture and portion size) listed in the food guideline, was in agreement with the patients' requests. Moreover, the proposed interventions in the food guideline concerning e.g. dietary advice, protected mealtime policy and availability of food and liquids on a regular basis, were also in agreement with the patients' requests. Importantly the variation in different food and liquids actually S363 consumed by the patients were less than suggested in the food guideline. Conclusions: At large, the guideline fulfilled its intention, i.e. to be in accordance with SCT patients' request for food and liquids, and interventions to increase their daily intake. A formal calculation of energy needs should be included in the guideline. More studies are needed on nutritional recommendations and dietary advice to improve oral intake during SCT. Based on our findings, the average cost of antiemetic therapy per patient at AUB-MC is higher than all the average costs of other guidelines (Figure 1 ). This is mainly due to the fact that antiemetic prophylaxis used during hospitalization was not interrupted 2 or 4 days after the end of the conditioning regimen, contrary to the different recommendations of the 3 guidelines. However, antiemetic control was similar to most published results. Based on these results, the medical and nursing teams at our center are developing guidelines to be implemented in the practice of using antiemetic therapy with the aim of improving costefficiency and hence making the procedure affordable to more patients.
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P1171 Cooperation between two units to assure the care of stem cell aphaeresis in children A. Soderstrand (1), K. Wass-Sahlberg (1), M. Portillo (1), A. Pilström (2) (1)Sahlgrenska University Hospital (Gothenburg, SE); (2)Queen Silvia`s Children Hospital (Gothenburg, SE)
This is an example of how quality work can enforce cooperation between two units in different parts of a city when patient safety is highlighted. In Goteborg, The Aphaeresis Unit at Sahlgrenska University Hospital and The Children's Oncology Ward at Queen Silvia's Children's Hospital are sited at different parts of the city. During many years stem cell aphaeresis always took place at the Aphaeresis Unit no matter if the patient was an adult or a child. Having no paediatric education, neither the nurses nor the doctors, the care of the patient not always could be as good as desirable while the stem cell were collected. When discussing this from a safety perspective during the process striving for JACIE accreditation, we realized that we needed to cooperate in a better way to provide a secure stem cell collection for children using both the paediatric and aphaeresis competences. Besides, going to another site also not benefi t the child and family to feel safe. Therefore to ensure the safety we have been making a reorganization. Instead of the child coming to the Aphaeresis Unit, the Aphaeresis Unit is now coming to the child (patient). Experienced nurses from the Aphaeresis Unit now always perform stemcell aphaeresis of children at the Children´s Hospital. An aphaeresis machine is transferred in advance. Routines is developed describing methods and the different responsibilities. Information material is developed using the different competences in purpose to make the child well informed. The child is examined by paediatrician before aphaeresis is started and during the aphaeresis if needed. Paediatric nurses are there to take care of the patient and the aphaeresis staff can provide a good collection. Purpose: The purpose is to secure the procedure concerning stem cell aphaeresis of children. Result: Routines gaining the purpose. More favourable environment for the child and the family to feel safe. Better competence effi ciency, aphaeresis staff can concentrate more on the collection and paediatric specialists is taking care of the child. Conclusions: Operational specifi cations have facilitated the work of the entire team and the inclusion of new nurses. Initial work has established a good basis for the material which then allowed the accreditation of the Joint Commissions International and the preparation of the JACIE inspection.
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Implementation of an oral care regimen in patients treated with haematopoietic stem cell transplantation J. Schilstra (1) Introduction: Patients undergoing hematopoietic stem cell transplantation (HSCT) for hematologic malignancies are at risk of developing oral complications. Problems include oral mucositis (OM), pain, swallowing dysfunction, infection, dry mouth, taste alterations, poor oral intake, bleeding, graft versus host disease, and dental caries. These complications affect patient's quality of life, are associated with high costs, and may have a negative impact on the treatment outcome. Evidence-based guidelines, including recommendations for oral care, have been developed for the management of OM. However, to successfully implement guidelines a systematic approach is mandatory in which barriers are identifi ed and addressed. Aim: To identify key factors crucial for implementation of an oral care protocol aimed at reducing OM, and to describe the implementation strategy in our institution. Methods: A well-defined systematic step-wise procedure was followed. A senior nurse (implementation coach, IC) was trained in effective leadership and implementation strategies. To identify factors that affect implementation a context analysis was performed, leading to an implementation diagnosis. Consequently, an implementation strategy was developed. Results: The context analysis identifi ed several factors, including inconsistent oral evaluation, absence of an assessment tool, reliance on tradition, and lack of interdisciplinary collaboration. A steering group consisting of nurses, a hematologist and a dentist was formed under IC leadership. Members were educated on risk factors, diagnosis of OM, and guidelines including oral care procedures. The oral care regimen was revised and educational materials were developed. Steering group members stimulated and coached other professionals involved. Clinical lessons were provided regularly. A scoring chart was developed and daily scoring of objective and subjective oral signs and symptoms was introduced. Interventions were linked to scoring outcomes. Information, new interventions and oral care products were introduced gradually. In addition, regular evaluation to ensure quality standards and identify barriers formed part of the process. Conclusion: Implementation is a time-consuming, complex and dynamic process that needs a well-defi ned structured approach. Constant adaptation and surveillance is mandatory. Future research is planned on the effi cacy of our efforts to implement guidelines aimed at reducing OM.
P1175
Introducing simple pre-admission measures can ensure parents are better equipped to deal with living away from home during the critical early admission period for children undergoing haemopoetic stem cell transplantation J. Cooper, H. Kettlewell NEBE (Newcastle, UK) The CBMTU in Newcastle upon-Tyne admits planned and emergency patients from a very large geographical area and accommodation is provided to parents free of charge.
Preparation for planned admissions is organised by an outreach team attached to the unit. Despite extensive preparation the authors recognise that families often arrive for admission without appropriate supplies of clothing, toiletries, entertainment and food for themselves or their child for their stay in an often unfamiliar city. The authors have reviewed the admission process by talking to families following admission and asking what would help their preparation for their time in hospital. Through these discussions the authors identifi ed that the families were so concerned with the treatment protocols that they didn't always remember basic needs. The families agreed a letter including a checklist of basic supplies required sent out a week prior to admission would be a useful reminder and could be faxed to outreach hospitals for emergency admissions. The format of the letter was reviewed by parents. Those who were asked unanimously agreed it would reduce some unnecessary stress at a diffi cult time and ensure they arrived in Newcastle better prepared for their stay. The presentation will describe the issues encountered as perceived by the families and staff and how simple measures could be introduced to ensure that families are equipped to deal with living away from home during the critical early admission period.
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Evaluation of platelet transfusion practice on a stem cell transplant unit: setting thresholds, setting standards L. McMonagle, N. Shepherd, T. Rintala, C. Harrison Guy's Hospital (London, UK) Platelet transfusions are frequently carried out on all Haematology and Stem Cell Transplant Units. The Blood Transfusion laboratory at Guys and St Thomas' NHS Foundation Trust identifi ed that platelets were often transfused outside of established guidelines and that a number of units were ordered, but not used, wasting approximately £2000 a month. A joint retrospective audit with the Blood Transfusion laboratory was established. The main objectives of the audit were: 1. Platelet transfusion are administered according to the blood transfusion policy. 2. All ordered platelet units are used or cancelled as appropriate. 3. Reason for platelet transfusion is documented in patients notes. The audit was initiated in October 2008 and all platelet transfusions in Clinical Haematology were included. Data was obtained from Blood Transfusion and reasons for poor compliance with the policy were investigated using patients' records. Furthermore, all staff (Medical and Nursing) were asked to complete a questionnaire to identify their level of understanding of the policy. Three key reasons were identifi ed for non-compliance from the data collection. 1. Team members were most likely to deviate from the policy when managing neutropenic patients with sepsis. There was lack of consistency depending on whether the patient was pyrexial, on antibiotics or cardiovascularly stable. 2. Existing Trust guidelines were not clear enough to specify responsibilities on the ward level, often meaning that agreed timelines were not met, particularly if the platelets were no longer required. 3. The indication for platelet transfusion was seldom documented in patient's notes as required by the policy. When platelet thresholds varied from the Trust guideline and were based on clinical judgment, reasons were rarely documented. Ongoing work to address issues identifi ed by the audit includes amending documentation and establishment of transfusion link nurses on the ward to highlight transfusion issues to the multidisciplinary team. The number of units wasted each month has been reduced by approx. 30%, although there is a tendency for waste to increase with each intake of new junior doctors. Future steps include exploring nurse prescribing of blood products to ensure consistency in transfusion decisions in order to guarantee effi cient use of this scarce resource and safe transfusions for all haematology patients.
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Continuous skin-temperature measurement during the neutropenic period in allogeneic stem cell transplant recipients F.P.M. Dinnissen, M. van Vliet UMC St. Radboud (Nijmegen, NL) Objective: Fever is almost the only signal of an impending infection after haematopoietic stem cell transplantation (HSCT). International guidelines suggest starting with antimicrobial therapy as soon as possible to prevent the developement of sepsis. Therefore early recognition of a temperature elevation is crucial to the successful treatment of infectious complications in neutropenic patients. Method: The feasibility and validity of a continuous non-invasive skin temperature measurement device was evaluated in cohort of 33 clinical patients during the neutropenic period following an allogeneic HSCT and was compared with standard temperature measurement (5 times during 24 hours using a digital thermometer). Result: Measuring skin temperature appeared to be feasible. Most of the patients did not experience any discomfort. The correlation between both simultaneously measured temperatures was good (Pearson r = 0.782). There was also a gain in time of 152 minutes in detecting fever compared to standard measurement. An elevated temperature could be observed early and when ≥38.5° blood cultures could be drawn and antimicrobial therapy could be started immediately. Conclusion: Continuous skin temperature measurement is a noninvasive method for the early detection of fever and is both feasible and reliable. After the study period the method was adopted as standard care. A nursing protocol was written and nurses were educated in the use of the skin-sensor. A leafl et was written to inform the patients. The quality of care was also improved through rapid recognition of fever thereby accelerating the management of infectious complications during neutropenia.
P1178 Patient satisfaction survey O. Brokka, D. Plaugher, R. Haynes Imperial College Healthcare NHS Trust (London, UK)
The Clinical Haematology unit at Imperial College Healthcare NHS Trust opened a new general haematology ward to care for pre and post transplant patients, sickle cell patients and other haematological disorders in 2008. After having been open for 8 months we decided to conduct a patient satisfaction survey. The reasons for this was that the ward staff was mainly oncology trained and new to haematology, the ward was understaffed and was running with a bed capacity varying from 10-16 beds depending on capacity issues in the unit. That ward also had different facilities than the other wards and the Trust scored poorly in a National In-Patient Survey. We also wanted to see if the Trust's values were refl ected in the care given. A questionnaire with 9 questions was given to all patients staying more than 24 hours on the ward regardless of diagnosis, condition etc. The survey was undertaken in June and July 2009. 24 questionnaires were handed out and 16 returned. The demographics of the populations refl ected the National Survey. Overall the results were uplifting and positive for the ward. The scores were generally better than the national survey, although some issues gave room for concern. These issues have been addressed and a new survey is will be undertaken in the spring. One concern raised from the survey was that the nurses did not know enough about the diseases and treatment the patient were undergoing. This highlights the importance of regular updates and training, and to have staff that is skilled and highly motivated in the team. Conclusion: This survey describes how patient satisfaction can change and improve the service provided, and that education and up skilling of nurses are of vital importance to patient satisfaction. The survey also showed that this ward was going in the right direction and patients were overall satisfi ed with the care they received. Although it was a small survey, it gave us a good insight in how to best go forward to improve patients experience as an in-patient on the ward. The Clinical Haematology unit at Imperial College Healthcare NHS Trust will be introducing electronic trackers, and conduct regular satisfaction surveys of all in-patients.
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Implementation of aseptic non-touch technique based on a change management approach: one unit's perspective
C. Stokes Avon Haematology Unit (Bristol, UK)
A recent review of practices in central venous catheter management highlighted variables in what should be a standardised approach. Guidelines were present and could be found on the trust intranet system, however not all staff were aware of this. Most new staff had been taught management guidelines from substantive staff. Current guidelines were lengthy, complicated and open to ambiguity. A base line audit refl ected the above. A review of central venous catheter management in other centres led to looking more closely at aseptic non touch technique (ANTT). In line with best practice guidelines (Pratt et al., 2006) it was decided that we should base our management of central venous catheters by using a standardised ANTT approach throughout our centre. The objectives were to standardise care of management of central venous catheters using the ANTT approach. All staff members were to be made aware of the change implementation and background to the change in order to support the change initiative. They would be educated in ANTT and taught how to use the technique. Ongoing audit and monitoring of practice would sustain the change and assist in compliance with the standardised approach. Methods included; attendence of an ANTT study day by a number of nurses from each clinical area, a fact sheet for staff about ANTT, a leafl et reminding staff of principles of infection control, a resource pack for staff and a roll out of teaching sessions throughout the centre. Successful implementation of ANTT using a change management approach shows a standardisation in central venous catheter management refl ected in ongoing auditing and monitoring of all staff.
P1180 The reduction of central-line infections A. Cabrera, Y. Harrington Imperial NHS Trust (London, UK)
Rationale: An audit highlighted an increase in line sepsis over a period of few months. These line infections have been attributed to a variety of pathogens, mostly skin commensal type organisms. Leading to: Increasing patient's admission Removal of central lines Increases in theatre attendances Increase in Intravenous drug administration Aim:
• To standardise practice for accessing peripheral and central lines.
• Observed and assess all practitioners on grand Union for Non-touch technique practices and accessing of lines.
• Assess hand hygiene and contamination of key-parts.
Key Parts: A key part is that part of the equipment that comes into direct contact with the liquid infusion e.g. needles, syringe tips, IV line connections, exposed lumens of catheters, tops of ampoules, etc. If any of these parts are contaminated there is risk of infection. Dos and Don'ts: Do:
• Follow the procedures.
• Use alcohol wipes, and use different parts to clean the bungs (key-parts).
• Allow the alcohol to dry.
• Be aware of the key parts.
• Clean all fl ip lids with alcohol once removed.
• Be aware of your practice and that it is kept up-to-date. Don't:
• Do not allow key areas to touch the sides of the tray etc..
• Do not draw up from plastic ampoule without a needle.
• Do not take needles to the 'bed-side'.
• Never fl ick off key-parts such as needles or caps. As you are likely to touch the key-part.
• Do not use intravenous fl uid bags more than once. Finally: Key-parts should NEVER be touched, only by other key-parts. Tell your colleagues if they are not following the principles of non touch technique. A Non-Touch: Technique is the single most important component for achieving asepsis. Evaluation: A further audit conducted after three months revealed a decrease in the number of line infections. Future plan:
• Produce written information for nurses.
• Continue assessment every year.
• Train all band sixes to assess their team members yearly.
• Focus on the care of Central Line Exit sites.
• Produce a SOP for care of Exit sites.
• Produce a quick step guide to exit site care.
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The Cutis leukaemia. Clinical case M.D. Alamo-Pulgares, M. Zarzana-Garcia, M. Ruiz-Seixas, M. Rey-Gonzalez HHUU Virgen del Rocio (Seville, ES) Introduction: Leukaemia cutis is defi ned as a rash produced by an infi ltration of Leukemic cells in skin. Usually appears during the course of an already diagnosed leukemia. Skin involvement as only a leukemia no expression in peripheral blood or bone marrow affectation manifestation is a rare event. 57 Years no history of interest, women diagnosed in 2001 of the cutis leukemia. It has had six recaída skin, the latter two with bone marrow involvement in 2008 and 2009. Expressed unwillingness to know treatments, side effects, therapeutic regime, procedures, Assessment is performed and activate related ineffective coping with acceptability of disease and deterioration in the health and expressed by advance mourning and anxiety at death. The patient make strategy of scape and avoidance. Responsibility of the disease and its process lies entirely within the family. Objetives: Acceptance of the state of health, decision-making. implementation of the role and problems facing. • Initial assessment of nursing.
• Selection of the diagnoses according to NANDA, NIC, NOC.
• Literature search. Objectives: To achieve maximum independence as soon as posible and control anxiety to the new situation. Results: Impaired physical mobility related to disease process, pain, weakness and poor knowledge.
NIC:
• Exercise-Therapy.
• Pain-management.
• Prevention of falls.
• Self-Aid: wc, hygiene, dressing / grooming. NOC:
• Levels of movility.
• Knowledge of the prescribed activity.
• Pain: adverse effects.
• Personal care for activities of daily living.
• Anxiety relacted to health and the environment. NIC:
• Emotional support.
• Decreased anxiety.
• Humor. NOC:
• Overcoming problems.
• Control of anxiety. Conclusions: Transverse myelitis and the subsequent reduction of movility (lower limbs paralysis), involves a signifi cant change in the patient´s besides emotional impact. Interventions focus on the basic needs of the pacient and the prevention of the consequences of the lack of movility. Emotional support and information to patient and / or family is key to acceptance and confrontation of the patient's situation. Nursing education in this fi eld is critical for proper intervention.
P1183 Heparinization of catheters P.M.F. Vivas, F. Banha, R. Pires IPOLFG (Lisbon, PT)
The use of a venous central catheter (CVC) on the therapeutic approach to the patient is more and more a reality in Health Care services in Portugal. The CVC as left to only used in intensive care units,haemodyalisis units and oncology units, been a usual presence in the differents clinical contexts. The nursing care to the person with a CVC demands from the nurse knowledge theorical-practical indispensable for the correct manipulation and support of this device, avoiding complications that can become of severe gravity. The formation of blood clots and subsequent obstruction of the catheter appears as one of the most frequent complications. However, it can be prevent, in the most of the cases, with a correct heparinization of the lumen. In this article, we describe the experience of the authors in this area, presenting the protocol that as been in use at the BMT-unit, whose results are positive. We hope contribute with experienced knowledge so that other health professionals may increase skills in their performance, uniform procedures having as goal increase the quality of nursing care.
P1184
Does expanded information about the importance of snacks and nutritional support give a better nutritional status to those who are treated with conditioning treatment for autologous stem cell transplantation? A randomized pilot study K. Lugnet, A. Svanberg Akademiska Sjukhuset (Uppsala, SE) Introduction: Patients, with haematological diseases, treated with conditioning treatment for autologous stemcell transplantation has an increased risk for malnutrition, due to vomiting/nausea, low calorie intake and weight loss. Nutrition is a major challenge at the haematological ward. The importance of snacks as nutritional support to patients is desirable. Objective: The objective with the present study was to evaluate if snacks offered to patient and received expanded support from hospital staff may have infl uence on nutritional status and hereby improve weight and amount of calories. Material and method: Sixteen patients, ± 18 years, with conditioning treatment for autologous stemcell transplantation at a haematological ward, were included consecutively. They were randomised to expanded information about the importance of snacks and nutritional support or to standard nutritional treatment at the ward for approximately 21 days. Weight and calorie intake were collected from the patient`s medical and nursing record. Result: The result indicates no difference in weight gain/weight loss between the groups. Patients receiving standard nutritional care received more parenteral nutritional support than patients receiving more nutritional support and extra snacks. The calorie intake was lower per os among patients with standard nutritional care. Conclusion: The result indicates that the weight result may be caused by the parenteral nutrition in the group of patients receiving standard nutritional care due to possible fl uid retention. Patients receiving extra snacks and nutritional support who supported themselves got better nutritional status.
Symptoms management P1185
Episil®: a bioadhesive oromucosal lipid solution, and oral cryotherapy to protect oral cavity and reduce oral pain for patients undergoing autologous stem cell transplantation
A. Svanberg Akademiska sjukhuset (Uppsala, SE)
Oral mucositis (OM) a complication in intensive chemotherapy, often requires advanced pharmacological pain treatment (PT). OM may further necessitate total parenteral nutrition (TPN) and may impair communication and sleep. PT has side effects such as nausea, constipation and loss of appetite. There is a lack of knowledge concerning effect of oral cryotherapy and bioadhesive oromucosal barrier forming lipid solution, Episil(1), on OM, oral pain and use of TPN for patients treated with superintensive chemotherapy before autologous stemcell transplantation (ASCT). Aim: The objective with the present study was to evaluate if oral cryotherapy in combination with Episil, during transplantation period may reduce number of days with OM, oral pain and use of TPN. Method: Patients ≥18 years (n = 12), scheduled for ASCT were included consecutively and randomised to experimental group (EXP) receiving oral cryotherapy in combination with Episil (n = 6) or control group (CTR) receiving cryotherapy (n = 6). All patients received oral cryotherapy from start of superintensive chemotherapy whereas EXP group started with Episil, at day three and used the solution until day ten after the ending of chemotherapy. The number of doses of TPN, oral pain registration using Visual analogue scale 0-10 (VAS), use of PT and grading of OM using WHO scale 0-4, was collected from the patient's medical and nursing record. Result: The result showed that less TPN was administered in the EXP group than in the CTR group (n = 0 vs. 11 doses). EXP group had less pain (VAS 3-5, eight registrations), compared to CTR group (VAS 3-6, seventeen registrations), less OM in the EXP group ( WHO 0/3 pat., 1/2 pat., 2/1 pat, four registrations) compared to CTR group (WHO 0/3 pat., 1/1 pat., 4/2 pat., sixteen registrations) and less use of PT. The EXP group used paracetamol when oral pain occurred whereas CTR group used paracetamol and tramadol in combination. Conclusion: Oral cryotherapy combined with Episil, resulted in fewer patients in need of TPN than oral cryotherapy alone. The combination treatment used for the EXP group also resulted in an reduction in oral pain compared with the CTR group and less use of analgesics. Pain scores were also lower in this group. OM graded using the WHO scale is indicated less frequently and less severely in the EXP group than in the CTR group for patients treated with superintensive chemotherapy before ASCT.
(1) Episil is a registered tradename of Camurus AB, Swe. Oral mucositis represents a signifi cant nursing and medical complication of the hematopoietic stem cells transplantation (HSCT). Observational trials on OM characteristics and risk factors are still warranted. Goal: to evaluate the characteristics of OM in the autologous HSCT patients after HD-L-PAM 200 mg/m² and BEAM conditioning regimens, to verify the impact of basic clinical and laboratory variables on OM incidence. Methods: prospective, observational and multicenter study in [2005] [2006] [2007] [2008] [2009] , OM assessed by the WHO criteria, univariate and multivariate analysis of basic clinical and laboratory variables (gender, age, body mass index, performance status, diagnosis, conditioning regimen, creatinin clearance, bilirubin levels, neutrophil count, diabetes mellitus, removable dentures (prosthesis), number of days since the last chemotherapy, number of CD34+ cells in the autologous graft and history of oral mucositis, oral cryotherapy). Patients: n = 126, age 57 (18-67) years, males 57%, BEAM conditioning regimen 46%, HD-L-PAM 200 mg/m 2 54%. Results: The cryotherapy was remarkably effective in respect to the reduction of OM incidence after the HD-L-PAM (melphalan 200 mg/m²) conditioning regimen (18% in cryotherapy vs. 68% without it, p < 0.0001) and even in the multidrug BEAM (melphalan 140mg/m²) regimen (38% vs. 86%, p = 0.006 ). In multivariate analysis, the fact of non-provided oral cryotherapy was the most signifi cant and independent risk factor for the OM development (p ≤ 0.0001), followed by the BEAM conditioning regimen (p = 0,02) and OM in a patient´s history (p = 0,01). The variables such as age, gender, body mass index, the baseline absolute neutrophil counts were not proved to have any negative impact on OM development. Discussion: Cryotherapy ( bedsides good oral hygiene) is the most important factor preventing the development of OM after melphalan containing high-dose chemotherapy.
P1186
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The impact of early virus infection on course and outcome of allogeneic stem cell transplantation: results of a single paediatric centre N.C. Davies, D. Bonney, J. Page, R. Wynn Royal Manchester Children's Hospital (Manchester, UK) Objective: To analyse outcome of stem cell transplant (SCT) when viruses were detected by intensive surveillance in the two weeks before and after SCT. Method: Data was obtained from retrospective case notes, and the hospital result database for children who had received an allogenic transplant in 2008 and 2009 . Viruses that were present in the blood, stool, urine and naso-pharangeal airway, from day -14 to day + 14, were recorded. Results: Forty fi ve allogeneic transplants carried out in 2008/2009. Eighteen (40%) children were positive for at least one virus from day -14 to day + 14 following transplant. Five (11%) of these children were positive for more than one virus. Eleven were male and seven female.
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The majority of these were from unrelated donors and for non malignant disease. Twelve were under the age of fi ve years, two under ten years, two under fi fteen years and two over fi fteen years. Six children had an immunological disorder, eight had a haematological disorder, while four children had a metabolic disorder. Five patients were positive for Cytomegalovirus (CMV). Eight children were positive for adenovirus in their stools while four of these were also positive for adenovirus in the blood. Four patients tested positive for norovirus in their stools. Two children had Epstein-Barr Virus (EBV) present. BK virus, Rotavirus, Enterovirus, and Rhinovirus all had one child each testing positive. Conclusion: All children post SCT are at an increased risk of developing viral infections, signifi cantly adenovirus, CMV and EBV. Children are monitored at least weekly by PCR testing of the blood, urine and stool. Part of the reason for improving results of allogeneic SCT in children is early detection and intervention in virus infection. We show that the detection of virus early post transplant is associated with a more complicated post transplant course but that a positive result leads in most cases to altered clinical management and, in most cases, to a still successful outcome. We emphasise the importance of virus screening in SCT transplant in this group of patients and the importance of keeping families and children supported and informed. Increased nurse education on the effects of viruses in the early stages of transplant helps families and children.
P1188 Finally something good E. Mourao, A. Correia, R. Pires ipolisbon (Lisbon, PT)
Introduction: Oral mucositis (OM) is one of chemotherapy side effects most feared by patients and generally overlooked, causing signifi cant pain, dysphagia and a risk factor for infection. Caphosol® (EUSA Pharma) is a supersaturated electrolyte oral rinse used to prevent severe OM. Purpose: To evaluate the effi cacy of Caphosol in prevention of severe OM in patients with haematological malignancies under autologous BMT receiving BEAM (Carmustine, Etoposide, Cytarabin and Melphalan). Methods: From February to September 2009 we used Caphosol mouthwash for prophylaxis of OM in ten adult patients (eight males and two females) with a medium age of 34.3 years after obtaining informed consent. Patients were advised to use caphosol after oral hygiene, up to four times a day. OM was evaluated daily by patients and by nurses: number of days with OM (using a WHO mucositis gradind scale), use of morphine and parenteral nutrition. Caphosol was given from day 1 of chemotherapy till the end of symptoms. We have matched this results with a homologous patients group, except for Caphosol. Results: Patients rinsed at least four times daily in 96% of the days. A clear decrease in OM was noted, when we compare with the control group. We found an increase in the number of days without mucositis. With the WHO pain scale we found a decrease in pain score; the use of morphine was also much lower on the Caphosol group. No Caphosol group patients needed parenteral nutrition support versus 5.4 days on average in the control group. Conclusions: The use of Caphosol resulted in a decrease in all grades of OM, also as in number of days with pain. Caphosol is highly effective on the control of OM and associated pain, causing a decrease on use of morphine and parenteral nutrition. Scales for Assessment of Oral Mucositis: NCI and WHO NCI Scale Grade 0 None Grade 1 Painless ulcers, erythema, or mild soreness in the absence of ulcers Grade 2 Painful erythema, edema, or ulcers but eating or swallowing possible Grade 3 Painful erythema, edema, or ulcers requiring IV hydration Grade 4 Severe ulceration or requiring parenteral or enteral nutritional support or prophylactic intubation Grade 5 Death related to toxicity WHO Grading Scale: Grade 0 None Grade 1 Soreness ± erythema, no ulceration Grade 2 Erythema, ulcers. Patients can swallow solid diet Grade 3 Ulcers, extensive erythema. Patients cannot swallow solid diet Grade 4 Oral mucositis to the extent that alimentation is not possible.
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Differentiated approach to pain syndrome management in nursing practice O. Ivanova, E. Antonova, Y. Oparina, Z. Urtaeva, I. Mushchitskaya , E. Semenova, B. Afanasyev SPb State I. Pavlov Medical University (St. Petersburg, RU) Pain is a complicated syndrome of unpleasant feelings associated with real or possible tissue damage and patient's emotional reaction on this damage. Emotional reaction causes suffering with different clinical presentation. Using of new analgesics and ways of their administration helped to reduce the frequency of pain syndrome (PS). But still pain syndrome makes patients suffering. The aim of the study: to provide the differentiated approach to pain syndrome (PS) management in hematopoietic stem cell transplant (HSCT) and chemotherapy nurse practice. Object: 48 patients (pts) were examined. Age: 7-28 years. Diagnosis: acute myeloblastic leukemia, acute lymphoblastic leukemia, aplastic anemia. Methods: Examination of clinical presentation and anamnesis, inquiring of patient about subjective sensation, valuation on visual analogue scale (VAS). Pain syndrome may differ depending on the diagnosis and treatment of the prior disease. Pts were separated into two groups: pts with somatic (nociceptive) PS (SPS) -32 pts 67% and pts with neuropathic PS (NPS) -16 pts 33%. In the fi rst group 4 pts (12 %) received chemotherapy and 28(88%) -HSCT. In the second group 11 pts (74%) received chemotherapy and 5 pts (26 %) -HSCT. SPS was caused by graft versus host disease (GVHD), mucosa and was reserved with opioids (morphine, phentanyl, NSAIDs, SAIDs) and treatment of the causes of pain. NPS was connected with chemotherapy and was arrested by tranquilizers, SAIDs and opioids (Tramadol). In a case of resistant NPS we use invasive therapy (epidural and peridural analgesia). Results: Low effi ciency of pain therapy was mentioned in 4 pts (12%) of the fi rst group, they had 6-10 VAS score. It was estimated as an imprecise differentiation of PS and inadequate PS management. 28 pts (88%) had 0-3 VAS score. In these pts warring reduction, sleep and mood advance were mentioned. Conclusions: Differentiated approach to PS management is necessary because analgesic effect is followed by other achievements such as sleep and mood advance, warring reduction, induce of social adaptation.
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Palonosetron versus ondansetron in CINV (chemotherapy-induced nausea and vomiting) S. Vieira, D. Monroe, R. Sorita, M. Palomar, M. Librojo, L. Porin, J. NG, A. Taylor The Trustee of London Clinic (London, UK) Introduction: Palonosetron is a longer acting 5-hydroxytryptamine-3 (5-HT³) antagonist, used in preventing chemotherapy induced nausea and vomiting (CINV). It is licensed initially for the oncology patient group. It is given as an injection and acts over a fi ve days period. Methodology: In our haematology setting we have conducted a small comparison study to compare the effi ciency of Palonosetron and Ondansetron for haematology patients for preventing CINV. Stage 1 data was collected prospectively for Palonosetron over a year period. Second stage data was collected for effi ciency of Ondansetron retrospectively, simply because Ondansetron is the main anti-sickness drug used in our centre. Patients who were in the Ondansetron group were selected randomly without any information by fl oor nurses. The information collected day 1-day 11 from the day chemotherapy started. There were 24 patients in each group. The data was compared in three different categories: complaints of nausea (severity), vomiting (how many episodes over 24 hour) and requirement of additional anti-sickness. The patients in both groups received similar chemotherapy regimens. Patient demographic data and chemotherapy regimen is shown in Table I . Outcome is tabulated and represented in line graphs, please see below. Outcome: The outcome is evaluated on two sections: severity of nausea and frequency of vomiting due to limited word count. According to our study, patient who received Palonosetron suffered less from mild nausea (See graph I & graph II). However in the evaluation of vomiting, there was a trend in the Palonosetron group. Those patients receiving Palonosetron had their sickness/ vomiting peak on day 4. Palonosetron was given day 5, where the vomiting subsidised again (see graph III & IV). However patient who received palonosetron 46% of them have not vomited thorough out the chemo while ondansetron group was 33%. Conclusion: Even though Palonosetron is manufactured for oncology patients, it is used for haematology patients. In our study Palonosetron was compared to Ondansetron. According to our study Palonosetron made a signifi cant difference in preventing and reducing the CINV. Unfortunately the data was collected retrospectively for the Ondansetron group. Therefore the limitation of this study is that there might be some bias due to poor documentation.
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Nursing challenges caring for a child with sudden bone marrow necrosis undergoing an allogeneic SCT I. Hvidt Rigshospitalet (Copenhagen, DK) A 4½ month old girl received an allogeniec SCT due to severe bone marrow necrosis and myolo dysplastic syndrome. The day she began conditioning with busulvex she went into respiratory and renal failure and was transferred to ICU. She was intubated, sedated and began hemodialysis. Conditioning consisted of busulves, ATG, cyclophosphamide. Day + 19 her blood tests showed signs of engraftment and she had symptoms of skin and bowl GvHD. Her condition improved, she was moved back to childrens`s ward doing well. Chimerism showed 90% donor cells. One month after day 0 her physical condition deteroriated with symptoms similar to the symptoms she experienced when she got ill. Four days later she went back to ICU with multi organ failure. She died 24 hours later probadly due to bone marrow necrosis. Nursing challenges: 1) transferring a child during transplantation to ICU, 2) skin breakdown with open wounds, 3) generalized edema, fl uid overload, capillary leak leading to respiratory and renal failure, impaired circulation, 4) bleeding from all insertion sites, mouth, ET-tube, nose, NGtube and melena due to low platelet count and DIC (dissiminated intravascular coagulation), 5) hemodialysis decreased the time left for intravenous medications and transfusions. Nursing interventions: 1a) The ICU room was prepared with a portable Laffl ow. BMT manuel was given to the ICU nurses. BMT nurses worked together with ICU nurses around the clock. Defi nition of roles and responsibilities between ICU and BMT nurses were established. ICU nurses were responsible for respiratory interventions including the ventilator, bloodpressure regulation and all drugs related to sedation and pain relief. BMT nurses were responsible for BMT related interventions including administration of all other drugs, 2a) bed bath once a day with sterile soap, rinsed with sterile water.Wounds were rinsed with sodium chloride, covered with paraffi n gauze dressings. Lotion was used on intact dry, fl aking skin. Change of position every 2 hours because of edema and easy brake down of dry skin, 3a) raising legs,arms 30-35 degrees increased circulation, 4a) gentle mouth wash, pressure applied to insertion sites, icepacks, using spongostan when possible. Priming hemodialysis fi lters with blood, 5a) to ensure that 15 drugs was given at the correct time in relation to hemodialysis a schedule was made to show nurses in which line, at what time and for how long each of the drugs should be given.
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Adverse reactions during infusion of autologous haematopoietic progenitor cells M. Felício, A. Santos, I. Cerqueira, G. Duarte Hospital Sao Joao, EPE (Porto, PT) Introduction: The transplantation of peripheral blood progenitor cells (PBPC) is a therapeutic procedure which is performed by intravenous infusion of stem cells for the purpose of restoring hematopoiesis after bone marrow failure, resulting from the conditioning regimen. Harvesting of PBPC is made by cytapheresis through cell separator, after their mobilization with growth factors and / or chemotherapy. Subsequently, they are cryopreserved at -196°C in solutions containing 10% of dimethyl sulfoxide (DMSO) to prevent cell destruction. Adverse events occurring during the infusion of the cells are usually attributed to the presence of DMSO. This study covers the year 2008 and was carried out at the Neutropenic Patients Unit at the Hospital São João, EPE.
Objectives: To analyze the occurrence of adverse reactions during the infusion of autologous PBPC; To relate the feedback with the volume of infused bag / DMSO; To develop and register a nursing care protocol during this procedure. Methodology: A retrospective study to determine the incidence of adverse reactions during the infusion of PBPC. The sample consists of patients who underwent auto-transplantation in the period January-December 2008. The variables include: sex, age, diagnosis, volume of infused bag, blood pressure, heart rate, facial fl ushing, epigastric pain, nausea and skin rash.
Results obtained: The sample consists of 57% women and 43% men, with a median age of 44. In the study population 47% are acute leukemia, lymphoma 33% and 20% multiple myeloma. After analyzing the results, it was found that 52% of transplant patients were infused with a volume greater than 200 ml. The most common adverse reactions were epigastric pain (81%), fl ushing (76%), bradycardia (61%), hypertension (57%) and rash (33%). For volume below 100 ml, only 25% had fl ushing and 50% epigastric pain. Between 100-200 ml, 83% had epigastric pain and fl ushing. In a 200 ml infusion, over 91% had facial fl ushing, 100% epigastric pain and 63% rash. It is important to highlight that the latter reaction was only found in this volume. Conclusion: Based on the results, it was found that adverse reactions are frequent and are integrally related to the infused volume/quantity of DMSO, which is consistent with the literature consulted.
P1193
Management of citrate toxicity in therapeutic aphaeresis procedures
A. Warwick Royal Free Hospital Hampstead (London, UK)
Citrate toxicity is a frequent occurrence in donor/patients during a therapeutic apheresis procedure. There are various ways to manage hypocalcaemia caused by the anticoagulant ACD-A which is used as an anticoagulant while the donor/patient is undergoing this procedure. I will show the different approaches to managing citrate toxicity whilst the donor/patient is undergoing an apheresis procedure. 24 hours prior to collection the patient/donor is advised to add calcium to their diet. Foods such as yogurt, cheese, and milk are some of the edible options that contain calcium. Another source is through vitamins. Information prior to the collection is helpful in trying to prevent the incidence of citrate toxicity. In all therapeutic procedures donors should have baseline blood tests which include an electrolyte assessment to verify corrected calcium levels before commencement of the procedure. Once attaching the donor/patient to the Cobe Spectra the technicians priority should focus on AC infusion rate and the amount that is delivered to the donor/patient. The guidelines from Caridian state that the normal range of ACD-A lies between 0.8-1.2 ml/min/L of the total blood volume for all procedures excluding TPE. The lower the AC rate, the less symptoms of toxicity should occur. When the toxicity does occur the severity should be evaluated. Oral calcium tablets, such as Calichew, are used to treat mild symptoms. If the donor/patient experiences moderate symptoms, such as muscle cramping, hypotension or nausea, the collection will be stopped briefl y while infusing saline and initiating an infusion of IV calcium. Reassessment of the symptoms must be evaluated to determine whether the donor/patient can continue. The principles of management of citrate toxicity include the administration of Calcium and a reduction or cessation in the citrate infusion. Alleviation of citrate toxicity includes the removal of plasma from the donor/patient and will give the nurse additional time to prepare an IV calcium. After the calcium is given, monitor for improvement. If the patient improves, slowly increase the speed of the collection to fi nish the procedure. If however the symptoms fail to cease there will be a more complex and lengthy delivery of IV Calcium with an elongated procedural end time.
Knowledge of severe symptom control, combined with an ability to identify and deliver emotional support, can make the collection process achievable in the most diffi cult of circumstances.
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Caphosol as a promising prophylaxis and treatment of mucositis during ASCT V. Ilemová, B. Silerová, E. Murdychová, B. Vackova, M. Trnkova, D. Pohlreich General Faculty Hospital (Prague, CZ) Introduction: Oral mucositis (OM) is one of the most frequent complications after autologous stem cell transplantation (ASCT). Transplant departments use a lot of procedures to prevent and cure symptoms of OM. We recorded the fi rst experiences with Caphosol. It´s an electrolyte solution (solution of phosphate-Caphosol A and solution of calcium-Caphosol B)destined for hydratation and oral cavity cleaning,including buccal mucosa, tongue and orofarynx. Goal: To verify the effect of Caphosol in patients with OM. Methods: Our patients wash out their oral cavities from the start of conditioning for 4-6 times a day with the saline solution or BiC. We started to administrate the Caphosol at the day when leucocytes decreased bellow 1.0 × 10E9/l. We recommended 4 lavages per day, possible up to 10 lavages per day in accordance to patient feeling. The Caphosol administration was fi nished when the patient was engrafted, had no OM symptoms and no problems in oral cavity limiting food intake per os.
Results: In 2009 we included into this analysis 10 patients. The oral pain was assessed during the Caphosol administration (the scale from 1-no pain to 10-intolerable pain). The highest grade of the pain: grade 10 -1 patient, grade 9-1 patient, grade 8-1 patient, grade 6-1 patient, grade 3-1 patient and grade 1-5 patients. Duration of this pain: no one day-5 patients, 7 days-1 patient, 10 days-3 patients, 11 days-1 patient. The administration of 1% Morphin due to the mucositis: the incipient dose always 30 mg/24 hours, lowering with a recessive pain. Morphin was administrated to our 4 patients by the time of intolerable pain (10 days-1 patient, 7 days-1 patient and 6 days-2 patients). Parental nutrition was necessary for 6 patients (60%), 4 patients (40%) were without parenteral nutrition. The median of inpatient days is 21 (16-24) days. Incidence of maximum OM grade: gr.0 in 2/10 (20%) patients, gr.1 in 3/10 (30%), gr.2 in 2/10 (20%), gr.3 in 2/10 (20%) and gr.4 in 1/10 (10%). Duration of OM: median 3.5 (0-11) days. Satisfaction of Caphosol: very satisfi ed-3 patients, satisfi ed-3 patients, slightly satisfi ed-2 patients and totally dissatisfi ed-2 patients. 3/10 patients felt a dryness in the mouth after the lavage of Caphosol. Pain is a frequent symptom in patients (pts) undergoing hemopoietic stem cell transplantation (SCT). Different origins and mechanisms (toxicity, complications, diagnostic procedures or S372 underlying disease) may be in charge and pain burden may be underestimated during SCT. To adequately assess frequency, intensity and mechanism of pain, a day-by-day assessment tool was designed and applied in pts undergoing autologous and allogeneic SCT in our transplant unit. Methods: Pain was assessed daily by nurses or doctors through pts interview; pain intensity was reported by a score of Numerical Analogue Scale (NRS), ranging from 0 (no pain) to 10 (the most severe), referring to the previous 24 hours. Site of pain was defi ned, as well as pathophysiology, to identify defi ned pain syndromes. Results: From November 2008 to October 2009, 27 SCT were evaluated (20 autologous, 7 allogeneic) in 25 pts. Diagnosis was multiple myeloma, lymphoma, acute leukemia and other diagnosis in 10, 10, 5 and 2 SCT, respectively. Median age at SCT was 46 (range 20-65). Observation ranged from the start of conditioning regimen to discharge (median days +14; range: 10-20). Pain was observed in 26/27 (96%) SCT with a mean pain intensity ranging from 0.1 to 5.4 (median = 2.6). Of the 26 pts presenting pain, maximal intensity was mild (score < 4), moderate (4-7) and severe (≥ 7) in 3 (12%), 10 (38%) and 13 (50%) SCT, respectively. Median pain duration expressed as the percentage of hospitalization period was 55% (range 11-100). 42 pain syndromes were identified, 7 before and 35 following conditioning regimen. The pain mechanism mainly recorded was mucositis (24/42 syndromes; 57%). The most frequent pain site was the mouth; the most frequent type was superficial somatic pain; complete data are reported in the Table. Conclusions: Pain is a frequent and multifaced issue during SCT. Larger series are needed to explore risk factors and to plan preventive strategies. The complexity of phenomenon suggests that a day-by-day pain assessing tools should be considered the standard for evaluation of pts undergoing SCT.
Education and support of nurses P1196 Information for haemo-oncological patients on preserving fertility M. Ruiz-Seixas, T. Gomez Ferriz, N. García Lafuente HHUU Virgen del Rocío (Sevilla, ES) The number of young patients affected by malignant neoplasias is growing. Specifi c treatments for managing these diseases are highly toxic to the gonads. Improving quality of life for those undergoing haemo-oncological treatment is the main objective if we examine the increase in survival rate for these diseases. Preserving gonadal function is an important aspect involved in improving quality of life. Frozen semen can be stored for males. For women, there are various techniques, some of which focus on preserving reproductive function by storing embryos or eggs. With these techniques, the patient must be fertile and undergo prior ovarian stimulation. In others,the objective is preservation or restoration of both the reproductive and endocrine functions, as occurs with chemical prophylaxis using GnRh analogues, progesterone or anovulatory drugs, or with cryopreservation of ovarian tissue to be implanted at a later date. In diseases with a high risk of death, these concerns become secondary and the importance of sterility/fertility to these patients is undervalued; often, the patient's right to complete, correct information is forgotten. Introduction: The objective of this investigation will be to measure the results that are derived from the professional practice of the nurse in relation to the improvement of the welfare process, in the improvement of the state of health of the patient and the benefi ts that provide the support to their family. Objective: To review the support available to pre-registration nursing students on the BMT unit. Method: Methods of support and resources available for preregistration nursing student discussed. Pre/post placement interviews and evaluation forms will be examined to assess students' progress throughout the placement and improve teaching standards on unit. Results: Pre-placement interviews highlighted individual students' fears and apprehension of working on the BMT unit. Named link nurses oversee student placement and allocate two trained mentors for each student. Initially the students' role is observational and as confi dence increases they take on a more active supervised role, with the aim that they will take a caseload relevant to their year of training. Resources such as a welcome pack, teaching board and regular meetings with link nurses/named mentors highlight the possibility of developing skills in basic nursing care through to high dependency and critical care skills. Visits to related areas are also encouraged, aiming to increase learning and improve experiences. Placement evaluation forms show that all students enjoy their time on BMT, stating that they learn a large variety of skills that can be used in future nursing practice in any area. They particularly appreciate being welcomed into the nursing team. Conclusion: The BMT unit provides a varied and exciting placement for student nurses. We have shown that with the right support and continuous monitoring, students from all backgrounds and levels of training can learn and develop skills and confidence in basic care through to critical care, including oncology and haematology nursing. Mentoring students also provides excellent opportunities for qualifi ed staff to improve their teaching skills, aiding staff development on the unit as a whole. Regarding Q2 the greatest obstacles in following training courses include support costs 58%, diffi culties in managing shift work 63% and the low number of specialist courses 59%. With respect to Q3 and 4 the data are represented in charts (1 and 2). Conclusions: The results confi rm the need for training and is supported by the high level of responses. Demand for training with innovative methodologies and procedures, despite a high level "expertise" wanting to get back into practical aspects and recognising the need for continuous updating. The GITMO Board propose to increase the number of educational courses annually, the implementation of regional courses to improve accessibility and construction of a bigger network with universities.
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The Austrian BMT/SCT NG members represent 14 centres and the group is a sub-organization of AHOP (Austrian Working group of haemato-oncological nurses). It is also an active member of the EBMT nurses group. The primary aims are exchange of knowledge and distribution of standards for clinical care. Workshops are held twice a year.
To identify the local standards of care a questionnaire on current practice in isolation, nutrition and hygiene measures was sent out. Twelve/14 centers responded and the results were evaluated in September 2008. It turned out that wide variation exists in isolation practice, infection prophylaxis, hygiene management and nutrition. Intensive and critical discussion on the different policies led to a restructuring of different nursing procedures. Old structures were challenged, adapted or partly exchanged.
Willingness to reconsider our own position and looking over the rim of our tea cup will ensure high quality of care at a reasonable cost. Nurses in the Netherlands, specialized in hemato-oncology, pursue collaboration and evidence-based consensus on a national level. In this context, the HOVON review committee has developed a standard format for nursing guidelines that accompany study protocols, which will be downloadable from the HOVON website, to be used in all future trials. Methods: Through various networks, nurses in hospitals working at a hematology ward, were contacted by email with the question what should be included in the standard guideline. Based on the responses, a standard format for nursing guidelines was proposed that was submitted to the review committee and fi nalized using their comments and recommendations. Results: Nurses from 21 hospitals (university medical centers and local hospitals) responded eventually. Most nurses send a copy of a local guideline as an example. Some guidelines contained entire treatment schedules and others were just an enumeration of chemotherapy and their administration. With the help of these data and the comments of the review committee, a standard format for nursing guidelines was developed. At this time this format is ready for implementation as a standard element of all HOVON study protocols. Conclusion: The HOVON review committee provides a great opportunity to stimulate collaboration, spread knowledge and create consensus. In this presentation we will describe the design and the implementation of the standard format of the nursing guideline and show its advantages. The next step will be to admit nursing interventions in this standard format.
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Nutritional support under a magnifying glass R. Morany, N. Hanna, S. Torati Sheba Medical Center (Ramat Gan, IL) Patients are malnourished if their diet does not provide adequate calories and protein for growth and maintenance or they are unable to fully utilize the meals they eat due to illness. Patients undergoing high dose chemotherapy followed by hematopoietic stem cell transplant (HCST) may experience a variety of abnormalities and gastrointestinal changes which leads to malnutrition. Impaired nutritional status before transplant is a negative prognostic factor for outcome after HCST and better nourished patients have a shorter time to engraftment. Nutritional support recommendations are now based on the nutritional status of the individual patient, and the oral route is preferred rather than total parenteral nutrition (TPN) as it is possible for having less complications. By promoting this issue among the staff, potential complications related to malnutrition can be prevented. Methods: Staff knowledge and attitude toward nutrition was assessed by a questionnaire. An intervention team including three nurses, physician and dietitian counselor was established for the purpose of promoting this issue based on literature review. As for today, an educational computerized program is being prepared for the purpose of expanding staff knowledge and providing them with the approved tools to promote this issue.
The staff knowledge will be examined after the educational program.
Results: All the nursing staff (27 nurses) completed the questionnaire. Fifty nine percent agreed that this subject is very valuable and in a high priority. 41% said that this issue is absolutely part of their job. 52% of them claimed that they can diagnose malnutrition among patients based on evidence based guidelines, 41% reported that lack of knowledge and approved tools prevents them from educating the patients. Knowledge part of the questionnaire included right, wrong & I don't know questions.
Results showed that there is a need for guiding principle improvement and knowledge expanding. Conclusion: Reported data showed that there is a real need for educating the staff regarding nutritional support in stem cell transplantation and an attitude change toward the subject. Caregivers are in a key position for preventing the patient's nutritional complications, decreasing suffer and mortality. Objective: Research reports regarding hematopoietic stem cell transplantation (STC) nursing published in Japan over the past 10 years were examined to clarify changes in STC nursing and to consider the requirements for continuing education. Methods: Two Japanese literature databases related to medical and nursing reports and abstracts from the Nursing Research Abstract Collection of the Japan Society for Hematopoietic Stem Cell Transplantation were used. This resulted in 105 research reports and 482 abstracts from which data on research background, and results were extracted and categorized. Results: The data were classifi ed into main topics such as: bacteriological testing in transplantation units; development of manuals and record forms for nursing procedures; methods of supplying information to pediatric patients; rehabilitation and collaboration with other healthcare professionals; and so on. Discussion: Changes in STC nursing over the past 10 years in Japan include: 1) Following guidelines from the 1999 US Centers for Disease Control and Prevention (CDC), methods for prevention of infections in SCT units were simplifi ed, and bacteriological examinations were performed and confi rmed; 2) The simplifi cation and diversifi cation of methods of transplantation occurred simultaneously. This means that patients with low self-care capability, for whom SCT was not indicated before simplifi cation, now undergo SCT, and many case reports on specifi c low self-care capability have been reported;
3) Because of simplifi cation, the time during which nurses provided direct patient care increased. However, 63% of nurses now working in SCT units in Japan have less than three years of experience in SCT nursing. As simplifi cation was rapidly implemented, confusion arose around nursing procedures resulting in the development of manuals and record forms; 4) In pediatric SCT, many children still undergo SCT without informed consent, which induces further problems especially if the patient deteriorates or becomes a long-term survivor. Thus, the nursing staff must cope with their own mental turmoil and ethical confl ict and 5) Shortening of admission periods promoted rehabilitation and required collaboration with other healthcare-related staff. Conclusion: SCT is a constantly under development. Nurses must play the role of innovators in solving newly arising problems. Ethical issues, low self-care capability and collaboration are potential topics for continuing education.
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Evaluation of an educational programme in management and care of central venous access devices M. Troeng Lund University Hospital (Lund, SE) Introduction: Long-term central venous access devices (CVAD), mainly central venous catheters (CVC) and implanted ports, are frequently used in patients with hematological malignancies. They are highly needed in order to administer chemotherapy, stemcell infusion and support therapy during the acute aplastic period. There is a further need in chronic phase. However, their use implies a serious risk for bloodstream infection that could become life-threatening for the neutropenic patient. Evidence consistently demonstrates that the risk of catheter related infection declines following standardisation of aseptic care and educating staff in aseptic practices (1). Purpose: The aim of the study was to evaluate an educational programme in management and care of CVADs by comparing adherence to practices in recommended evidence-based guidelines between nurses that had participated in the educational programme and those who had not. Methods and Results: Structured observations of adherence to the guidelines were performed using a checklist from a previous study (2). Specifi ed behaviours of hygiene precautions, aseptic care and antisepsis were defi ned to be observed when a nurse changed a CVC dressing or accessed a port by inserting a needle. Obervational data from 46 nurses in the educational group and 41 nurses in the comparison group were analyzed statistically. The results show that the nurses who had participated in the educational programme had signifi cantly fewer deviations (mean 0,8) from the recommended guidelines than the nurses who had not (mean 3,5). The deviations in the comparison group had the character of incomplete performance in the various behaviours. Conclusions: The educational programme made the nurses adhere to the recommended guidelines in a way that even the details in the procedures were carried out according to evidence. M.A. Grau Ruiz, F.J. Gonzalez Fernández, M.J. Bárcena Gómez, P. Agüeros Fuente Hospital Marqués de Valdecilla (Santander, ES) Introduction: Catheter associated infections (BCR) are the main cause of nosocomial bacteremia and are related to high morbidity and mortality. In Spain, it is estimated that around 9% of deaths every year are directly linked to BCR.
There is a multitude of studies on BCR in Intensive Care Units, but hardly any exist on haematology units which have conclusive results, perhaps due to the nature of the haematological illness in which there are mainly long periods of neutropenia, severe mucositis, cell immunosuppression, etc. The programme ZERO BACTEREMIA, which the Cantabrian Health Service has joined, proposes that procedures be standardised, checklists be made and that mistakes be learned from. We can highlight the following key points: -Adequate hand hygiene. -Skin disinfection using chlorhexidine. -Barrier measures during insertion. -Frequent use of the subclavian vein instead of the femoral vein. -Removal of unnecessary lines. -Hygienic handling of catheters. With this project, it is our intention that all of the health staff who work in the haematology unit receive training on this project and we intend to compare its effectiveness in haematological patients. Main aim: The fundamental aim of our project is designed to reduce the adverse effects related to the insertion and maintenance of central lines in haematological patients. Material and methods: Al professionals will do the course on "Zero Bacteremia", "Zero Tolerance" and "Catheter Care and Maintenance" on offer in the Sofos platform, which belongs to the Training Department of the Cantabrian Health Service. Analysis of data: We will carry out a comparative prospective study with background checks. The sample will be made up of 50 patients from each branch. 1 year, from January 2010 to October 2010.
Conclusions:
We fi nd ourselves in a position where it is necessary to make decisions. The following tests will be carried out: -Analysis of potential failure modes. -To determine the potential effects and cause of the failure. -To identify current monitoring systems. -To determine the evaluation index of each failure mode. -To propose strategies for improvement. In addition to this, we can add the comments of Dr Provonost, in which he says: -That personal effort does not control everything, but the system does. -Healthcare is a "team sport". -There should be more communication and plans decided upon together.
P1208 What's in a name? -Practice Development Matron L.G. Furlonger Nottingham University Hospitals (Nottingham, UK)
Historically at NUH we had pockets of Practice Development Nurses (PDN's), Governance nurses and clinical educators across the two trusts. There were a myriad of titles and huge variation in role and responsibilities. Some staff was ward or speciality based, as in the stem cell transplantation unit and some were working across divisions. In 2006 the two trusts merged and had a large fi nancial defi cit to overcome, resulting in a reorganisation, which became a driver too what was exactly required from a practice development role for the future. The challenge to drive forward the Practice Development agenda in a large, split campus organisation, with a £6.8 million fi nancial defi cit, was not underestimated.
There is now 29 Practice Development Matron's (PDM's) across the trust which has created cohesive teams of PDM's both within directorates and across the Trust and consistency in roles and responsibilities. In stem cell transplantation there is one PDM. As a new PDM in stem cell transplantation there has been a delivery of the agenda below within the stem cell transplant unit. Quality and Patient Safety Developing a Learning Culture Sharing Best Practice A PDM achieves this agenda through trust committees and objectives, which have helped the stem cell unit, achieve a consistent way of working within the trust. Also allows access to the best researched ways of working. However this is not to say it is not a 'Two Way Street' as the PDM has much contact with the staff within the stem cell unit therefore allows feedback of ideas that infl uence standards and quality patient care across the trust. Many challenges have presented themselves over the last 2 years, some of which have been overcome, others that are ongoing and new challenges that will accompany the delivery of workloads and expectation that come from the Corporate, Directorate and the stem cell specialty agenda within which Practice Development Matron is involved. The aim is to present an experience with intensive nurse care about hemato-oncological patients underwent hematopoietic stem cell transplantation in three centers. Despite the proclamation and need of unifi ed complex approach to the patients in transplant care units, there was found out to be quite diffi cult to achieve that and some signifi cant differences were evident among the centers. Presented study evaluated the level of nurse care, hygiene and transplant units equipment, the system of patients isolation and the preparation of meal in three transplant centers (Zurich, Pilsen, Olomouc). One of possibilities how to unify and standardized the majority of approaches to transplant patients and how to improve the cooperation among the centers is an active participation of nurses on the programs of exchange stays in various departments.
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An integral part of intensive nurse care improving is the continual education in this fi eld of hemato-oncology. The program of education was initiated 2008. Hemato-oncology Department of University Hospital in Pilsen leads and coordinates this program but practical education in intensive nurse care is provided in all transplant and hemato-oncological centers in the Czech Republic.
